See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Research Area · Inflammation
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords | Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10976 |
10- |
14113-05-4 | ≥98% |
|
2011-10-13 | 79.840110497237 | 10-hda | fatty acids royal jelly lifespan MMP RA, rheumatoid arthritis VEGF angiogenesis antitumor neurogenesis collagen | 79.840110497237 | |||
| 10008128 |
10(S),17(S)- |
871826-47-0 | ≥98% |
|
✓ | 2007-08-21 | 106.761685082873 | 10-s-17-s-dihdohe | PDX; Protectin DX | inflammation resolution resolvins neuroprotection neurodegeneration Alzheimer's disease NPD1 PD1 RvE1 dihydroxy DHA 10S,17S dihydroxy DHA anti-inflammatory neuroprotectin d1 protectin d1 10(s), 17(s)-dihdohe protectin-dx protectindx | 106.761685082873 | |
| 20140 |
12- |
136696-10-1 | ≥95% |
|
2009-03-06 | 26.550049723756 | 12-oxo-leukotriene-b4 | 12-keto LTB4; 12-oxo LTB4 | LTB4 metabolism PMNL neutrophils inflammation chemotaxis chemokinesis 12-keto leukotriene B4 12-keto-leukotriene B4 | 26.550049723756 | ||
| 34560 |
12(R)- |
82337-46-0 | ≥98% |
|
37.568213627992 | 12-r-hete | hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases | 37.568213627992 | ||||
| 10007247 |
12(R)- |
82337-46-0 | ≥98% |
|
2009-02-17 | 21.069848066298 | 12-r-hete-lipid-maps-ms-standard | hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases MS mass spectrometry standards | 21.069848066298 | |||
| 10010425 |
13,14- |
- | >98% |
|
✓ | 2008-05-09 | 0.087679558011 | 13-14-dihydro-15-keto-prostaglandin-d1 | 13,14-dihydro-15-keto PGD1 | PGD1 prostaglandins metabolites DGLA dihomo-.gamma.-linolenic acid dihomo-gamma-linolenic dihomo-y-linolenic PGDs pathways | 0.087679558011 | |
| 13100 |
13,14- |
- | ≥95% |
|
✓ | 2009-10-28 | 54.045005524862 | 13-14-dihydro-15-keto-tetranor-prostaglandin-d2 | PGDM metabolites PGD2 CRTH2 DP2 tetranors agonists prostaglandins receptors CRTH2/DP2 | 54.045005524862 | ||
| 13101 |
13,14- |
20675-85-8 | ≥95% |
|
✓ | 2009-10-23 | 15.885055248619 | 13-14-dihydro-15-keto-tetranor-prostaglandin-e2 | PGEM metabolites 13,14-dihydro-15-keto PGE2 CRTH2 PGs tetranorPGEM tetranor-PGEM | 15.885055248619 | ||
| 20150 |
14,15- |
114616-11-4 | >97% |
|
2008-06-02 | 41.183911602210 | 14-15-dehydro-leukotriene-b4 | 14,15-dehydro LTB4 | leukotrienes inflammation leukocytes antagonist LTB4 5-LO 5LO allergy asthma LTs inhibits inhibitors inhibition | 41.183911602210 | ||
| 10009286 |
14(15)- |
218461-97-3 | ≥95% |
|
2007-05-14 | 23.609134438305 | 14-15-eet-si | 14(15)-EET-sulfonimide; 14(15)-EpETrE-SI | arachidonic acid AA endothelium epoxytrienoic acid EETs EpETrEs cytochromes P450 acetylcholine bradykinin sulfonamide analog tyrosine phosphorylation mitogenesis renal epithelial cells hypertension EDHF | 23.609134438305 | ||
| 10011360 |
14,15- |
75290-60-7 | >95% |
|
2008-05-23 | 42.751123388581 | 14-15-leukotriene-c4 | EXC4; Eoxin C4; 14,15-LTC4 | leukotrienes inflammation leukocytes 5-LO 15-LO 12-LO 5LO 15LO 12LO epoxytrienes asthma allergy pulmonary diseases eoxin inflammatory | 42.751123388581 | ||
| 10011362 |
14,15- |
1000852-57-2 | ≥97% |
|
2008-11-15 | 52.545722178374 | 14-15-leukotriene-e4 | 14,15-LTE4; EXE4; Eoxin E4 | leukotrienes inflammations leukocytes 5-LO 5LO 15LO 15-LO 12-LO 12LO epoxytrienes asthma allergy pulmonary disease eoxin cyslts cysteinyl leukotrienes | 52.545722178374 | ||
| 10011677 |
15- |
- | Whole cell lysate | ✓ | 2008-06-17 | 17.794347641309 | 15-lipoxygenase-1-western-ready-control | 15-LOX-1 Western Ready Control; 15-LO-1 Western Ready Control | proteins 15LO1 lipoxygenases 15(S)-HETE 13(S)-HODE 15S-HETE 13S-HODE interleukins western blots WBs immunoblotting blotting | 17.794347641309 | ||
| 10011263 |
15- |
- | >95% |
|
2008-03-25 | 38.109361571516 | 15-lipoxygenase-2-human-recombinant | 15-LO-2; 15-LOX-2 | arachidonic acids recombinant proteins 15-HETE 15-HpETE active | 38.109361571516 | ||
| 10010468 |
15- |
928853-86-5 | ≥98% |
|
✓ | 2008-10-23 | 34.525699815837 | 15-lipoxygenase-inhibitor-1 | 15-LO Inhibitor 1 | 15-LOs inhibitors inhibits inhibition oxidation inflammation thrombosis cancers lipoxygenases pyrimidobenzothiazine antioxidants | 34.525699815837 | |
| 10174 |
16(17)- |
- | ≥90% |
|
2004-01-14 | 34.388830570902 | 16-17-epdpe | 16,17-epoxy Docosapentaenoic Acid; 16,17 EDP | epoxides epoxygenases cytochrome P450 (±)16,17-EpDPEs (+/-)16,17-EpDPEs fatty acids (+/-)16(17)EpDPEs 16(17)EETs eicosatrienoic neurochemistry 16,17-EDP 16,17EDP | 34.388830570902 | ||
| 11036 |
17- |
467214-20-6 | ≥98% |
|
2012-03-14 | 20.000000000000 | 17-dmag | NSC 707545; KOS-1022; Alvespimycin | inhibitors inhibits inhibition heat shock proteins Hsp90 geldanamycin cancers inflammation renal failure tissues tumors NF-κB mice mouse diabetes KOS1022 KOS 1022 NSC-707545 NSC707545 | 20.000000000000 | ||
| 13532 |
17- |
- | ≥98% |
|
✓ | 2010-05-04 | 345.648555643251 | 17-phenyl-trinor-prostaglandin-e2-ethyl-amide | 17-phenyl trinor PGE2 ethyl amide | 17-phenyl trinor PGE2 agonists EP1 EP3 receptors EP4 smooth muscles contraction fertility prostaglandins PGs | 345.648555643251 | |
| 10005099 |
17(R)- |
155976-53-7 | ≥98% | ✓ | 2005-01-05 | 25.056148382005 | 17-r-hdohe | 17(R)-hydroxy Docosahexaenoic Acid | resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry | 25.056148382005 | ||
| 13060 |
17(R)- |
528583-91-7 | ≥95% |
|
✓ | 2008-12-18 | 127.184952347746 | 17-r-resolvin-d1 | AT-RvD1; 17(R)-RvD1; Aspirin-triggered-Resolvin D1 | EPAs DHAs resolvins inflammation antiinflammatory anti-inflammatory immune response aspirin LOXs 17R ATRvD1 17RRvD1 10007848 | 127.184952347746 | |
| 10009799 |
17(S)- |
- | ≥98% |
|
2007-03-12 | 13.789244935543 | 17-s-hdohe | 17(S)-hydroxy Docosahexaenoic Acid | resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe | 13.789244935543 | ||
| 13185 |
17(S)- |
- | ≥98% |
|
2009-07-02 | 9.532513812154 | 17-s-hpdohe | 17(S)-hydroperoxy Docosahexaenoic Acid | inhibitor inhibitors inhibits DHA 17S-HpDOHE 17SHpDoHE mono-oxygenation 17(S)-resolvins 17S-resolvins TNFs TNF-α TNFα 17(s)-hpdohe 17s-hdohe | 9.532513812154 | ||
| 20170 |
18- |
102674-12-4 | ≥97% |
|
2009-02-24 | 260.950419889502 | 18-carboxy-dinor-leukotriene-b4 | 18-carboxy dinor LTB4 | LTs leukotrienes metabolism β-oxidation β oxidation liver LTBs | 260.950419889502 | ||
| 10175 |
19(20)- |
- | ≥98% |
|
2004-01-14 | 40.950773480663 | 19-20-epdpe | 19,20-epoxy Docosapentaenoic Acid; 19,20 EDP | metabolites epoxides epoxygenases cytochrome P450 (±)19,20-EpDPEs (+/-)19,20-EpDPEs fatty acids (+/-)19(20)EpDPEs 19(20)EETs eicosatetraenoic 19,20-EETs neurochemistry 19,20-EDP 19,20EDP | 40.950773480663 | ||
| 10009431 |
1- |
- | ≥99% deuterated forms (d1-d8) |
|
✓ | 2009-07-24 | 8.713674033149 | 1-stearoyl-2-arachidonoyl-pc-d8 | SAPC-d8; 1-Stearoyl-2-Arachidonoyl Phosphatidylcholine-d8 | SAPC LDL oxidation inflammation cardiovascular disease phospholipids LC/MS GC/MS deuterated deuteriums mass spectrometry MS LC-MS GC-MS standards | 8.713674033149 | |
| 10006330 |
2,3- |
- | >98% |
|
2005-03-02 | 69.753749013417 | 2-3-dinor-thromboxane-b1 | 2,3-dinor TXB1 | metabolites thromboxanes urine urinary 2,3-dinor-TXB2 11-dehydro TXB2 biosynthesis humans rats markers rabbits | 69.753749013417 | ||
| 9000683 |
25- |
19356-17-3 | ≥98% |
|
2012-01-12 | 62.289278752437 | 25-hydroxy-vitamin-d3 | RO 8-8892; Rovimix Hy-D; U 32070E; 25-hydroxy Cholecalciferol | 25631-40-7 calcidiol calcifediol calderol dedrogyl didrogyl hidroferol Hy-D Ro 8-8892 Rovimix Hy-D U 32070E U-32070E U32070E 25-OH cholecalciferol 25-OH vitamin D3 25-hydroxyvitamin D3 phosphorus metabolism neuromuscular inflammatory intermediates receptors livers kidneys plasma serum | 62.289278752437 | ||
| 13222 |
2- |
94944-70-4 | ≥95% |
|
2009-10-08 | 42.741312154696 | 2-acetyl-5-tetrahydroxybutyl-imidazole | THI; 2-ATHBI; 2-Acetyl-4-tetrahydroxybutyl Imidazole | sphingosines-1-phosphates S1P lyases S1PL inhibitors lymphatic tissues lymphocytes egress thymus lymphoid organs lymphopenia immunosuppression THI | 42.741312154696 | ||
| 10007980 |
3,4- |
- | ≥95% |
|
2006-08-09 | 1.842265193370 | 3-4-daa | Trp tryptophan Multiple Sclerosis MS T helper-1 TH1 cytokines EAE encephalomyelitis inflammation immunity autoimmune autoimmunity cells cytokines | 1.842265193370 | |||
| 10397 |
3- |
3544-24-9 | ≥98% |
|
2011-10-07 | 2.107037223058 | 3-amino-benzamide | 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline | poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated | 2.107037223058 | ||
| 9000785 |
3- |
6736-58-9 | ≥98% |
|
2011-06-14 | 1.138121546961 | 3-deazaadenosine | c3Ado; deaza-Ado; DZA | S-adenosylhomocysteine hydrolases homocysteine S-adenosylmethionine methyltransferases inhibitors SAH anti-inflammatory NF-κB NF κB NF kB anti-viral anti-bacterial inflammation infectious diseases leukocytes chemotaxis lymphocyte-mediated cytolysis phagocytosis degranulation signaling 3-DZA ado inhibits inhibition SAM | 1.138121546961 | ||
| 10008445 |
3- |
- | >98% |
|
2006-05-25 | 35.313121546961 | 3-methoxy-limaprost | 3-methoxy-2,3-dihydro-Limaprost; 3-methoxy-17α,20-dimethyl-Δ2-Prostaglandin E1 | PGE1 prostaglandins platelets aggregation inhibits inhibitors inhibition analog ADP collagen-induced adhesiveness | 35.313121546961 | ||
| 13265 |
4- |
1011268-23-7 | ≥98% |
|
✓ | 2010-06-16 | 136.023106200123 | 4-hydroxy-nonenal-alkyne | Click Tag™ 4-HNE alkyne | lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT | 136.023106200123 | |
| 11094 |
4- |
1314230-75-5 | ≥98% |
|
2012-02-28 | 32.235202229476 | 4-quinolone-3-carboxamide-furan-cb2-agonist | 4Q3C CB2 Agonist | cannabinoids CBs agonists receptors CB1 CB2 AM630 pain neuroscience osteoporosis inflammation anti-inflammatory bones research peripheral AM630 AM 630 AM-630 | 32.235202229476 | ||
| 10007820 |
5- |
- | 2006-09-13 | 10.769070818684 | 5-lipoxygenase-phospho-ser523-polyclonal-antibody | 5-LO (Phospho-Ser523) Polyclonal Antibody | wb western blotting blots antibodies regulation leukotrienes asthma fibrosis atherosclerosis inflammation regulating phospho-specific immunoblotting | 10.769070818684 | ||||
| 10006618 |
5- |
- | 2005-03-07 | 0E-12 | 5-oxoete-receptor-blocking-peptide | TG1019; R527 | antibodies western blotting blots signaling signalling WB ICC immunocytochemistry 5-oxo-ETE receptors controls peptides proteins eicosatetraenoic acids PUFAs polyunsaturated fatty | 0E-12 | ||||
| 100025 |
5- |
- | 2004-12-14 | 255.799907918968 | 5-oxoete-receptor-polyclonal-antibody | TG1019; R527 | WB western blots blotting ICC immunocytochemistry 5-HETEs oxo-acids chemotactic chemotaxis 5-lipoxygenases 5-oxo-etes leukocytes PUFAs stimulators eosinophils neutrophils GPCR G-proteins coupled Gi/o cAMP cyclic inflammatory kidney liver receptors antibodies antisera antiserum 5oxoete immunoblotting | 255.799907918968 | ||||
| 90420 |
5(S),14(R)- |
98049-69-5 | >95% |
|
2008-11-17 | 36.819287906691 | 5-s-14-r-lipoxin-b4 | 5(S),14(R)-LXB4 | LXB4 trihydroxy fatty acids leukocyte activation LXA4 inflammation lipoxins inhibits inhibition inhibitiors | 36.819287906691 | ||
| 90415 |
5(S),6(R),15(R)- |
171030-11-8 | ≥95% |
|
2008-11-17 | 107.479164364641 | 5-s-6-r-15-r-lipoxin-a4 | 5(S),6(R),15(R)-LXA4; AT-Lipoxin A4; 15-epi Lipoxin A4 | inflammations lipoxins aspirins ASA neutrophils inflammatory aspirins triggered | 107.479164364641 | ||
| 10005032 |
5(S),6(R)- |
- | ≥95% |
|
2007-06-13 | 50.358149171270 | 5-s-6-r-7-trihydroxymethyl-heptanoate | BML-111 | lipoxins metabolites arachidonic acids AA lipoxygenases A4 LXA4 chemotaxis neutrophils PMN leukotrienes B4 LTB4 FMLP analogs inhibition plymorphonuclear | 50.358149171270 | ||
| 10009999 |
5(Z),11(Z),14(Z)- |
7019-85-4 | ≥98% |
|
2007-08-08 | 2.471284530387 | 5-z-11-z-14-z-eicosatrienoic-acid | Sciadonic Acid; 5,11,14,20:3 | inflammation PUFA fatty acids MPSO maritime pine seed oil Pinus pinaster inflammatory (5z,8z,11z)-eicosa-5,8,11-trienoic acid | 2.471284530387 | ||
| 10010484 |
5(Z),14(Z)- |
122055-58-7 | ≥98% |
|
✓ | 2008-11-21 | 21.262417127071 | 5-z-14-z-eicosadienoic-acid | fatty acids polyunsaturated PUFAs | 21.262417127071 | ||
| 10878 |
7(R)- |
1268720-28-0 | ≥95% |
|
2012-02-01 | 136.325964929138 | 7-r-maresin-1 | 7(R)-MaR1 | docosahexaenoic acids DHA macrophages zymosan inflammation phagocytosis fatty brain retina murine peritonitis FITC 7(R) maresin 1 mar 1 | 136.325964929138 | ||
| 10546 |
7(S),17(S)- |
887752-13-8 | ≥98% |
|
✓ | 2010-10-22 | 4.518093922651 | 7-s-17-s-dihydroxy-8-e-10-z-13-z-15-e-19-z-docosapentaenoic-acid | 7(S),17(S)-hydroxy DPA | opxylipin docosanoid DPAs DHAs protectins D1 anti-inflammatory fatty acids | 4.518093922651 | |
| 13161 |
7(S)- |
1268720-66-6 | ≥95% |
|
✓ | 2010-08-19 | 76.025180136701 | 7-s-maresin-1 | 7(S)-MaR1 | docosahexaenoic acids DHA macrophages zymosan A inflammation phagocytosis lipids zymosan-A peritoneum FITC-labeled FITC labeled mouse murine mice 7,14-dihydroxy 14S-hydroperoxy 887752-49-0 inflammation antiinflammatory anti-inflammation antiinflammation Docosahexaenoic Acid | 76.025180136701 | |
| 13655 | Adapalene | 106685-40-9 | ≥98% |
|
2010-09-10 | 3.225635359116 | adapalene | Differin; CD 271 | agonists retinoic acids differentiation anti-inflammatory inflammation antiinflammatory anti inflammatory RARs RAR-β RARβ β RAR-b RARb RARbeta RAR-beta RAR-.beta. RAR.beta. RAR-γ RARγ RARg RAR-g RARgamma RAR-gamma RAR.gamma. RAR-.gamma. CD-271 CD271 Naphthalenes | 3.225635359116 | ||
| 13297 |
AG- |
118409-62-4 | ≥95% |
|
2009-07-14 | 5.198800315706 | ag-126 | Tyrphostin AG-126 | tyrphostins proteins tyrosine inhibitors inhibits inhibition cells growth epidermal growth factors receptors kinase GFRK EGFs EGFRK PDGF PDGFRK platelet-derived platelet derived phosphorylation ERK1 p44 ERK2 p42 TNF-α TNFα TNF α NF-κB NFκB NF κB COX-2 COX2 iNOS inflammation | 5.198800315706 | ||
| 19023 | AH 23848 (calcium salt, hydrate) | - | ≥90% |
|
2009-02-26 | 76.191248618784 | ah-23848-calcium-salt-hydrate | AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 | 76.191248618784 | |||
| 10010241 | AICAR | 2627-69-2 | ≥98% |
|
2008-02-25 | 204.096817679557 | aicar | NSC 105823; Acadesine; AICA Riboside | AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide | 204.096817679557 | ||
| 10010332 |
AMP- |
216758-20-2 | ≥95% |
|
✓ | 2008-11-21 | 7.960876023905 | amp-deoxynojirimycin | Adamantane-pentyl-dNM; N-(5-adamantane-1-yl-methoxy-pentyl)-Deoxynojirimycin; AMP-dNM | inhibitors inhibits inhibition ceramides lipids glycolipids glucosylceramide synthase glucosylceramidase β-glucosidase 2 glucosidase sphingomyelin deoxynorjirimycin nojirimycin inflammation antiinflammatory anit-inflammatory hapten colitis insulin sensitivity resistance SREBPs sterol genes expression cholesterol HepG2 cells | 7.960876023905 | |
| 13144 | Anacardic Acid | 16611-84-0 | ≥98% |
|
2010-02-12 | 5.862559731964 | anacardic-acid | 6-pentadecyl Salicylic Acid | HAT histones acetylation P300 pCAF transcription NF-κB IκBα p65 6-pentadecyl salicyclic acids NSC 623096 cyclogallipharic 229596 333857 | 5.862559731964 | ||
| 11001 | Anatabine | 2743-90-0 | ≥95% |
|
2011-11-10 | 0.160220994475 | anatabine | alkaloids solanaceae tobacco Alzheimer’s diseases amyloid beta Aβ β-secretase BACE-1 NF-κB inflammation urine nicotine transcription proteins SHSY-5Y cells | 0.160220994475 | |||
| 500840 |
Anti- |
- |
|
2012-02-14 | 46.808728740115 | anti-ovalbumin-ige-mouse-eia-kit | EIAs ELISAs enzymes immunoassays immunometric kits assays measures measurements immunizations mice mouse with chicken egg albumin OVA precipitate complexes aluminum hydroxides alum TH2-mediated immune immunity response OVA/alum immunized anti-OVA antibody antibodies IgG1 isotypes mediates tissues tissue-specific effectors models chronic inflammation allergy allergic asthma rhinitis cutaneous hypersensitivity levels plasma serum blood immunoglobulin OVA-specific plate-bound biotin-labeled monoclonal | 46.808728740115 | ||||
| 500830 |
Anti- |
- |
|
2011-11-21 | 81.754843281696 | anti-ovalbumin-igg1-mouse-eia-kit | EIAs enzymes immunoassays immunometric kits assays measures measurements eggs whites immunization mice mouse chickens albumin OVA precipitate complexes aluminum hydroxides alum TH2-mediated immune response immunity OVA/alum immunized anti-OVA antibodies IgG1 IgE isotypes mediate tissue-specific tissues effectors chronic inflammation allergic asthma rhinitis cutaneous hypersensitivity antibody plasma serum immunoglobulin OVA-specific TH2 | 81.754843281696 | ||||
| 10010275 | Apigenin | 520-36-5 | ≥98% |
|
2008-02-18 | 194.735082872928 | apigenin | Versulin; NSC 83244; Flavone; Chamomile | flavonoids flavones CK2 inhibitors inhibits inhibition inflammatory response anti-inflammatory anti-oxidant NO PGE2 iNOS COX-2 I.kappa.B.alpha. NF-.kappa.-B renal cortex | 194.735082872928 | ||
| 10008463 | ApoAI Polyclonal Antibody | - |
|
2006-03-30 | 31.128004143646 | apoai-polyclonal-antibody | Apolipoprotein A-I; Apolipoprotein AI | atherosclerosis proteins diseases antibodies antisera antiserum WB western blotting ICC immunocytochemistry ApoA1 ApoA-1 Apo A-1 Apo A1 Apo AI Apo-A1 Apo-AI blots immunoblotting | 31.128004143646 | |||
| 90010 | Arachidonic Acid | 506-32-1 | ≥98% |
|
68.865479363016 | arachidonic-acid | fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential | 68.865479363016 | ||||
| 10007466 |
Arachidonic Acid- |
- | >98% |
|
2005-11-30 | 26.445758133824 | arachidonic-acid-biotin | fatty acids PUFAs polyunsaturated biotinylated affinity probes binding proteins cellular cells esterified membranes phospholipids regulated pathways substrates biosynthesis eicosanoids messengers receptor-stimulated release metabolisms re-uptake signalling inflammation detection detected complexes elucidations transports FABPs biotins biotinylated | 26.445758133824 | |||
| 10008617 | Arachidonic Acid Leelamide | - | ≥95% |
|
2006-09-27 | 14.271160220994 | arachidonic-acid-leelamide | AA cannabinoids central peripheral CB1 CB2 CP55940 PDK pyruvates dehydrogenases kinases anti-inflammatory inflammation phospholipases PLA2 inhibits inhibitors inhibition cannabinoids cbs sythetic | 14.271160220994 | |||
| 10007268 | Arachidonic Acid Lipid Maps MS Standard | 506-32-1 | ≥98% |
|
2009-07-06 | 18.887808471454 | arachidonic-acid-lipid-maps-ms-standard | fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential MS mass spectrometry standards | 18.887808471454 | |||
| 13622 |
AS- |
1146702-72-8 | ≥98% |
|
✓ | 2010-01-25 | 14.118729281768 | as-041164 | phosphoinositides 3-kinases PI3K cells growth migration metabolism inhibitors inhibits PI3Kα PI3Kβ PI3Kγ PI3Kδ chemotaxis inflammation neutrophils AS041164 AS-041164 RANTES | 14.118729281768 | ||
| 10009052 |
AS- |
900515-16-4 | ≥95% |
|
2007-01-30 | 25.573676284018 | as-252424 | phosphoinositides 3-kinases PI-3 PI3-K Phosphatidylinositol inhibitors PI3K .gamma. inhibition inhibitory PtdIns AS252424 | 25.573676284018 | |||
| 10010175 |
AS- |
648449-76-7 | ≥98% |
|
✓ | 2007-07-23 | 11.889067253257 | as-604850 | phosphoinositides 3-kinases PI3-kinase PI3-K phosphatidylinositol inflammatory drugs inflammation arthritis rheumatoid peritonitis neutrophils recruitment PtdIns inhibitors inhibits inhibiton PI3K | 11.889067253257 | ||
| 10007707 |
AS- |
648450-29-7 | >98% |
|
2007-06-13 | 15.216846364194 | as-605240 | phosphoinositide 3-kinases PI3-kinase PI3-K PI3K phosphoinositide phosphatidylinositols inibitors inflammation arthritis rheumatoid peritonitis neutrophils recruitment as605240 | 15.216846364194 | |||
| 9000980 |
AS- |
- | ≥98% |
|
✓ | 2011-03-25 | 14.786789441375 | as-605240-potassium-salt | phosphoinositides 3-kinases PI3-kinases PI3-K PI3K phosphatidylinositols inhibitors inflammation arthritis rheumatoid peritonitis neutrophils recruitment as605240 as 605240 PIs salts solubility soluble | 14.786789441375 | ||
| 13160 |
AT- |
162640-98-4 | ≥95% |
|
✓ | 2010-06-22 | 6.983799877225 | at-56 | Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid Lysosomal Proton Translocating ATPases Vacuolar Proton-Translocating ATPases Vacuolar Membrane H(+)-ATPase Proteins Membrane-Associated Membrane-Associated Proteins Membrane Associated Proteins Tacrolimus Binding Proteins Proteins Rapamycin-Binding Proteins Integral Membrane Membrane Proteins Integral Binding Proteins Rapamycin Rapamycin-Binding Proteins Rapamycin Binding Proteins Protein Integral Membrane Integral Membrane Proteins Vacuolar F(1)F(0) ATPasesLysosomal F(1)F(0) ATPase Integral Membrane Protein Vacuolar F(1)F(0) ATPase Proteins Cell Membrane Protein FK-506-Binding Proteins Cell Surface Protein FK506-Binding FK-506-Binding ProteinFK506 Binding Proteins FK 506 Binding Protein Cell Membrane Proteins FK506-Binding ProteinFK506 Binding Protein Cell Surface Proteins H+-ATPase, Vacuolar Vacuolar H+-ATPase Vacuolar H+ ATPase Proteins Membrane Proteins Vacuolar ATPase Rotamase FKBP V Type ATPase FKBP Rotamase Membrane FKBP | 6.983799877225 | ||
| 10277 |
ATB- |
912758-00-0 | ≥98% |
|
2008-11-11 | 5.087592435188 | atb-337 | ACS 15; S-Diclofenac | inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfides gasotransmitter vasodilator atb337 ACS-15 ACS15 ACS S SDiclofenac Diclofenac | 5.087592435188 | ||
| 13045 |
ATB- |
1000700-26-4 | ≥98% |
|
✓ | 2008-11-09 | 2.921846578835 | atb-343 | inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfide gasotransmitter vasodilator atb343 | 2.921846578835 | ||
| 600140 | Autophagy/Cytotoxicity Dual Staining Kit | - |
|
2009-07-14 | 80.606732438832 | autophagy-cytotoxicity-dual-staining-kit | assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis | 80.606732438832 | ||||
| 10803 | Autotaxin (human recombinant) | - | ≥95% |
|
2011-04-04 | 14.860662983425 | autotaxin-human-recombinant | Ectonucleotide Pyrophosphatase/Phosphodiesterase-2; Lysophospholipase D; ENPP-2 | lipids hydrolysis lysophophatidyl choline lysophophatidic acids secreated glycosylated active | 14.860662983425 | ||
| 700580 | Autotaxin Inhibitor Screening Assay Kit | - |
|
2011-06-28 | 16.120036832412 | autotaxin-inhibitor-screening-assay-kit | ATX Inhibitor Screening Assay Kit | kits assays measures measurements Ectonucleotides Pyrophosphatase-2 ENPP-2 Lysopholipases D hydrolysis lysophosphatidylcholines LPC lysophosphatidic acid LPA lipids mediators G protein-coupled receptors GPCRs neurogenesis angiogenesis smooth-muscles contraction platelets aggregations wounds healings ATX-LPA signaling tumors progression inflammation serums proteolytically peptides proteins N-glycosylation Asn53 Asn410 adipocytes cerebrospinal fluid multiple sclerosis livers fibrosis cancers genes chips analysis upregulated metastatic inhibits inhibition human | 16.120036832412 | |||
| 10011336 |
Avenanthramide- |
955382-52-2 | ≥95% |
|
✓ | 2009-06-18 | 63.084175874769 | avenanthramide-c-methyl-ester | Inhibitors NF-κB IL-6 IL-8 MCP-1 IκB inhibits inhibition Interleukins | 63.084175874769 | ||
| 13823 | AX 048 Exclusive | 873079-69-7 | ≥98% |
|
✓ | 2010-09-15 | 7.192651933702 | ax-048 | Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids | 7.192651933702 | ||
| 10010266 |
BAY- |
19542-67-7 | ≥98% |
|
2008-07-25 | 33.128187845303 | bay-11-7082 | inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 | 33.128187845303 | |||
| 10960 | Bisdemethoxycurcumin | 24939-16-0 | ≥98% |
|
2011-08-09 | 23.565733578882 | bisdemethoxycurcumin | BDMC | curcumin activators macrophages phagocytosis 1α,25-dihydroxyvitamin D, amyloid-β Alzheimer’s diseases cancers transcription genes expression p300 Wnt/β-catenin iNOS inflammation bisdemethoxy curcumin 33171-05-0 | 23.565733578882 | ||
| 11073 | Bisindolylmaleimide XI (hydrochloride) New | 145333-02-4 | ≥98% |
|
2012-03-21 | 37.214390955495 | bisindolylmaleimide-xi-hydrochloride | Ro 32-0432 | 131848-98-1 Ro32-0432 Ro-32-0432 Ro-320432 Ro 320432 Ro320432 PKC isozymes Staurosporine inhibitors inhibits inhibition proteins kinases C PKCα PKCβI PKCε hydrochloride HCl cells hearts T-cell T cell inflammatory inflammation | 37.214390955495 | ||
| 11071 |
BRD2 bromodomain 1 (human recombinant; GST- |
- | ≥95% |
|
2011-10-21 | 21.617085211800 | brd2-bromodomain-1-human-recombinant-gst-tagged | RNF3; Bromodomain containing 4; RING3 | BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host | 21.617085211800 | ||
| 11070 |
BRD2 bromodomain 2 (human recombinant; GST- |
- | ≥95% |
|
2011-10-21 | 19.476201233899 | brd2-bromodomain-2-human-recombinant-gst-tagged | RING3; RNF3; Bromodomain containing 4 | BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host | 19.476201233899 | ||
| 11069 | BRD2 bromodomains 1 and 2 (human recombinant) New | - | ≥90% |
|
2011-12-20 | 22.742155953254 | brd2-bromodomains-1-and-2-human-recombinant | Bromodomain containing 2; RNF3; RING3 | BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases | 22.742155953254 | ||
| 11068 |
BRD4 bromodomain 1 (human recombinant; GST- |
- | ≥60% |
|
2011-10-21 | 31.131678012537 | brd4-bromodomain-1-human-recombinant-gst-tagged | MCAP; Bromodomain containing 4; HUNK1 | BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts | 31.131678012537 | ||
| 11066 |
BRD4 bromodomain 2 (human recombinant; GST- |
- | ≥95% |
|
2011-10-21 | 23.292605823785 | brd4-bromodomain-2-human-recombinant-gst-tagged | MCAP; Bromodomain containing 4; HUNK1 | BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts | 23.292605823785 | ||
| 11052 | BRD4 bromodomains 1 and 2 (human recombinant) New | - | ≥90% |
|
2011-12-20 | 25.119793084056 | brd4-bromodomains-1-and-2-human-recombinant | HUNK1; Bromodomain containing 4; MCAP | BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases | 25.119793084056 | ||
| 10009599 | Calcipotriol (hydrate) | 112828-00-9 | ≥98% |
|
2008-02-08 | 84.621139758542 | calcipotriol-hydrate | Calcipotriene | vitamins D3 receptors calcium calcitriols JunB inflammations psoriasis skin irritations keratinocyte cells proliferations differentiations T immune response | 84.621139758542 | ||
| 13285 | Cannabidiol dimethyl ether | 1242-67-7 | ≥98% |
|
2009-05-19 | 8.183425414364 | cannabidiol-dimethyl-ether | Cannabidiol-2',6'-dimethyl ether; CBDD | 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic | 8.183425414364 | ||
| 13907 |
Caspase- |
- |
|
2010-07-12 | 2.067774269928 | caspase-1-monoclonal-antibody-clone-14f468 | IL-1β Converting Enzyme | antibodies caspases caspase1 cysteine proteases cell death apoptosis prodomain catalytic subunits receptors ligand growth factor CED-3 CED3 western blots blotting immunoblotting WB immunohistochemistry IHC proteins IL-1β ICE IL1β IL-1b IL1b apoptosis inflammatio | 2.067774269928 | |||
| 70635 | CAY10416 | 443919-96-8 | >95% |
|
2007-07-24 | 31.926498618784 | cay10416 | COX-2 cyclooxygenases 5-LO lipoxygenases inflammation inhibitors prostates cancers PC3 LNCaP carcinomas apoptosis inhibition inhibits chemotherapy cells lines | 31.926498618784 | |||
| 10007955 | CAY10498 | 863202-33-9 | ≥98% |
|
2006-08-02 | 41.749779005525 | cay10498 | 2-phenyl-amino-N6-endo-norbornyladenine | adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology | 41.749779005525 | ||
| 10008657 | CAY10502 Exclusive | - | ≥98% |
|
✓ | 2007-08-02 | 3.096629834254 | cay10502 | cPLA2.alpha. phospholipases inflammation inhibitors inhibits inhibition arthritis inhibitory cPLA2 AA arachidonic inflammatory inflammation 3-methyl hydrogen 1-[3-(4-decyloxy phenoxy)-2-oxopropyl] indole-3,5 dicarboxylate | 3.096629834254 | ||
| 10009536 | CAY10512 Exclusive | 139141-12-1 | ≥97% |
|
✓ | 2007-07-18 | 28.156942909760 | cay10512 | analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis | 28.156942909760 | ||
| 10010088 | CAY10526 Exclusive | 938069-71-7 | ≥98% |
|
✓ | 2007-09-07 | 383.213084714549 | cay10526 | mPGES-1 mPGES1 microsomal prostaglandin E2 PGE2 synthase prostanoid modulators inflammatory inflammation pain inhibition inhibitors inhibits expressions | 383.213084714549 | ||
| 10010032 | CAY10570 Exclusive | 875014-22-5 | >98% |
|
✓ | 2008-06-03 | 11.915980662983 | cay10570 | FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids | 11.915980662983 | ||
| 10011248 | CAY10575 | 916985-21-2 | ≥95% |
|
2008-09-03 | 24.234925019731 | cay10575 | IKKε IKK-ε IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition NF-κB | 24.234925019731 | |||
| 10011249 | CAY10576 | 862812-98-4 | ≥95% |
|
2008-09-08 | 31.565377532228 | cay10576 | IKK-.epsilon. IKK.epsilon. IKK-epsilon IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition | 31.565377532228 | |||
| 10012424 | CAY10583 Exclusive | 862891-27-8 | ≥98% |
|
✓ | 2009-07-21 | 61.190257826887 | cay10583 | LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation | 61.190257826887 | ||
| 13164 | CAY10589 Exclusive | 1077626-52-8 | ≥98% |
|
✓ | 2009-06-23 | 2.900145027624 | cay10589 | Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling | 2.900145027624 | ||
| 13181 | CAY10590 Exclusive | 1101136-50-8 | ≥98% |
|
✓ | 2009-04-15 | 14.872604577742 | cay10590 | sPLA2 cPLA2 iPLA2 phospholipases inhibitors R-gamma-nonleucine inhibition inhibited secreetory regulates phagocytosis foam cells | 14.872604577742 | ||
| 10012553 | CAY10595 Exclusive | 916047-16-0 | ≥97% |
|
✓ | 2009-07-08 | 8.011823204419 | cay10595 | DP2 PGD2 CRTH2 chemotaxis inflammation antagonists prostaglandins PGDs | 8.011823204419 | ||
| 10012539 | CAY10597 | 916046-55-4 | ≥98% |
|
2009-03-11 | 3.705348066298 | cay10597 | DP2 PGD2 CRTH2 chemotaxis inflammation antagonist 5-chloro-1'-[(2-fluorophenyl)methyl]-2,2',5'-trioxo-spiro[3H-indole-3,3'-pyrrolidine-1(2H)-acetic acid | 3.705348066298 | |||
| 13281 | CAY10598 Exclusive | 346673-06-1 | ≥98% |
|
✓ | 2010-05-07 | 55.690121546961 | cay10598 | Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection | 55.690121546961 | ||
| 10009796 | CAY10602 | 374922-43-7 | ≥95% |
|
2009-07-15 | 19.163443830570 | cay10602 | SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB | 19.163443830570 | |||
| 13381 | CAY10606 | 1159576-98-3 | ≥98% |
|
2009-12-04 | 118.757262682069 | cay10606 | 5-lipoxygenases 5-LOs leukotrienes LTs LTB4 arachidonic acids inhibitors inhibit neutrophils blood ionophore A23187 formyl peptides fMLP lipopolysaccharides LPS reversed pleurisy inflammation inflammatory inhibition | 118.757262682069 | |||
| 13615 | CAY10614 Exclusive | 1202208-36-3 | ≥98% |
|
✓ | 2010-03-22 | 11.377624309392 | cay10614 | 1115270-65-9 Lipids A endotoxins lipopolysaccharides LPS gram-negative bacterias infections toll-like receptor 4 TLR4 immune responses antagonists sepsis inflammation | 11.377624309392 | ||
| 13695 | CAY10638 Exclusive | - | ≥98% |
|
✓ | 2010-10-01 | 25.700034530386 | cay10638 | Thiazolidinedione derivative | prostaglandins 15-PGDHs thiazolidinediones inhibitors inhibits inhibition TZDs derivatives PGDHs dehydrogenases | 25.700034530386 | |
| 10804 | CAY10649 Exclusive | 1272519-89-7 | ≥98% |
|
✓ | 2011-04-04 | 16.559235727440 | cay10649 | 5-LO leukotrienes 5-lipoxygenases inhibitors inflammation smooth muscle contraction inhibition inhibited PMNL inflammatory | 16.559235727440 | ||
| 10743 | CAY10650 Exclusive | 1233706-88-1 | ≥98% |
|
✓ | 2011-06-14 | 12.111933701657 | cay10650 | cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 | 12.111933701657 | ||
| 11140 | CAY10657 New | 494772-86-0 | ≥98% |
|
2012-03-05 | 15.173864708261 | cay10657 | NF-κB, transcription factors inflammation arthritis chemotherapy IKK IKK2 inhibitors IKB thiophenecarboximide inhibits inhibitions IKK-2 IKK 2 NFkB NF kB Rel NF-kB/Rel pro-inflammatory genes cytokines chemokines interferons MHC proteins growth factors cells adhesion cancers | 15.173864708261 | |||
| 10010398 |
CB- |
432047-72-8 | ≥98% |
|
2009-06-30 | 38.500490737732 | cb-13 | CRA-13 | cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 | 38.500490737732 | ||
| 10010117 |
CB- |
869376-90-9 | ≥98% |
|
✓ | 2007-10-25 | 20.362948895028 | cb-52 | cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists cannabinoids cbs synthetic | 20.362948895028 | ||
| 10009852 |
CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT- |
- | 2008-09-03 | 0.417248618784 | cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8 | antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 IF immunofluorescence | 0.417248618784 | |||||
| 10232 | CD5 Monoclonal FITC Antibody (Clone CRIS1) | - | 2009-08-10 | 4.756431860036 | cd5-monoclonal-fitc-antibody-clone-cris1 | Tp67; T1; Leu1 | antibodies CDs flow cytometry immunocytochemistry ICC FC B-cells T-cell B T IHC IF immunofluorescence immunohistochemistry | 4.756431860036 | ||||
| 13519 | Celastramycin A Exclusive | 491600-94-3 | ≥97% |
|
✓ | 2010-01-25 | 1.674033149171 | celastramycin-a | inhibits inhibitors bacterias mycobacterias inflammation IL-8 IL 8 IL8 HUVECs endothelial cells TNF-α TNFα TNF α inhibition interleukins tumors necrosis factors TNF alpha TNF.alpha. inflammatory bioactive endophytic celastraceae pyrroles | 1.674033149171 | ||
| 13322 | CGP 57380 | 522629-08-9 | ≥95% |
|
2009-08-28 | 32.518664825046 | cgp-57380 | MNK1 Inhibitor | inhibitors inhibits inhibitions MAPKs MAP kinases interacting interacting-kinase 1 MNK1 p38 JNK1 ERK1/2 PKC Src-like phosphorylation elF4E TNF-a TNF-α TNFα TNFa arsenite anisomycin PMA fetal calf serum 293 cells RAW264.7 toll-like receptors TLR2 HKLM TLR4 LPS TLR6/2 FSL TLR7 imiquimod TLR9 CpG DNA CGP57380 CGP-57380 | 32.518664825046 | ||
| 10325 |
Chemokine- |
- |
|
2010-01-25 | 63.879109883364 | chemokine-like-receptor-1-polyclonal-antibody | GPCR ChemR23; Resolvin E1 Receptor; ChemerinR; DEZ; CMKLR1; ChemR23 | immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR | 63.879109883364 | |||
| 16831 | Cicaprost Exclusive | 94079-80-8 | ≥98% |
|
✓ | 2010-09-16 | 48.114404821697 | cicaprost | ZK 96480 | Prostaglandin I2 PGI2 prostacyclins vasodilators cardiovascular diseases inflammation mitogenesis cancers orally active inflammatory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)-Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX | 48.114404821697 | |
| 10858 |
Cinnamyl- |
132465-11-3 | ≥97% |
|
2011-06-28 | 17.917223756906 | cinnamyl-3-4-dihydroxy-cyanocinnamate | CDC | inhibitors 5-LO 5LO 12LO 15LO 5 LO 12 LO 15 LO 12-LO 15-LO LTB4 lipoxygenases immune responses inflammation inhibits inhibition A23187 platelets shock assays | 17.917223756906 | ||
| 10004235 |
cis- |
61434-67-1 | >98% (may contain 1-5% trans) |
|
2008-02-05 | 30.205534069981 | cis-resveratrol | (Z)-Resveratrol | antioxidant oxidative stress reactive oxygen species reactive nitrogen species ROS RNS NF-kb inflammations monoamine oxidase noradrenaline inhibits inhibitor inhibitions NF.kappa. atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors | 30.205534069981 | ||
| 9000760 | Colchicine | 64-86-8 | ≥98% |
|
2011-05-25 | 19.853603437692 | colchicine | microtubules polymerization mitosis anti-proliferation anti-inflammatory gout uric acids antiinflammatory antiproliferation | 19.853603437692 | |||
| 10009624 |
COX- |
- | Whole cell lysate | 2007-04-30 | 56.917545382794 | cox-2-human-western-ready-control | Cyclooxygenase-2; Prostaglandin H Synthase 2 | western blots WB PGHS-2 Prostaglandin H Synthase 2 cyclooxygenase 2 | 56.917545382794 | |||
| 10010096 |
COX- |
- | ✓ | 2008-04-23 | 29.459263351749 | cox-2-mouse-polyclonal-fitc-antibody | Prostaglandin H Synthase 2; PGHS2; Cyclooxygenase 2 | antibodies prostaglandins thromboxanes prostacyclins arachidonic acids FC flow cytometry ICC immmunocytochemistry WB western blots blotting immunoblotting IF immunofluorescence | 29.459263351749 | |||
| 700200 | COX Fluorescent Activity Assay Kit | - |
|
2008-07-24 | 82.566610334741 | cox-fluorescent-activity-assay-kit | Cyclooxygenase Fluorescent Activity Assay Kit | cyclooxygenases synthases enzymes cox-1 cox1 cox-2 cox2 prostaglandins PGs synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity cellular homeostasis antiinflammatory NSAIDs nonsteroidal anti-inflammatory drugs fluorescence human recombinant ovine isozyme-specific inhibits inhibitors inhibition ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin | 82.566610334741 | |||
| 13183 | CP 80633 | 135637-46-6 | ≥98% |
|
2010-05-20 | 10.566906077348 | cp-80633 | phosphodiesterases PDE cAMP cGMP asthma neurological diseases inhibitors inhibits inhibition PDE4 PDE1 PDE2 PDE3 PDE5 inflammation CP-80,633 CP-806333 CP80633 Pyrimidinones Pyrimidones | 10.566906077348 | |||
| 10011236 |
C- |
- |
|
2009-04-22 | 312.046850828728 | c-reactive-protein-human-eia-kit | CRP (human) EIA Kit | atherosclerosis proteins hepatocytes adipocytes plasma blood inflammatory inflammation physiological pathological atherogenesis endothelial coagulation ICAM-1 VCAM-1 E-selectin LDL macrophages plaques immunometric assays enzyme immunoassay ELISAs | 312.046850828728 | |||
| 580200 | CTRP3 (human) EIA Kit New | - |
|
2012-01-20 | 7.725669358266 | ctrp3-human-eia-kit | Complement C1q TNF-related Protein 3 | kits assays EIAs ELISAs enzymes immunoassays measures measurements complements C1q TNF-related tumors necrosis factor-relateds proteins 3 secreted glycoproteins morphogenesis metabolisms cells functions cellular paralog adiponectins adipocytes leukocytes blood chondrogenic differentiations bone cartilage angiogenesis ERF1/2 signaling signalling adipokines mice mouse humans recombinants suppresses suppression hepatic livers glucose sugar C6H12O6 output inhibition inhibits inhibitors gluconeogenesis levels normal ob/ob obese/obese antagonizes lipopolysaccharides LPS toll-like receptors 4 TLR4 competitive serums plasmas cultures supernatants | 7.725669358266 | |||
| 10329 |
Cystathionine γ- |
- | ≥85% |
|
2010-02-19 | 19.902173112339 | cystathionine-lyase-human-recombinant | CTH; Cystathionase; CGL | cystathionases CTH CGL cystathionines gamma-lyase γ homocysteine transsulfuration cysteines hydrogen sulfides cystathionine gamma-lyase proteins enzymes .gamma.-lyase g-lyase active | 19.902173112339 | ||
| 10009291 | Cysteinyl Leukotriene Express EIA Kit | - |
|
2008-08-11 | 254.400657960824 | cysteinyl-leukotriene-express-eia-kit | CysLT Express ELISA Kit | solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs | 254.400657960824 | |||
| 10961 | Demethoxycurcumin | 22608-11-3 | ≥98% |
|
2011-09-23 | 4.766151012890 | demethoxycurcumin | DMC | curcumin cancers transcription genes expressions p300 Wnt/β-catenin iNOS inflammation proliferation cells p300 coactivator inhibits lipopolysaccharides inhibitor inhibition | 4.766151012890 | ||
| 11015 | Dexamethasone | 50-02-2 | ≥98% |
|
2011-10-25 | 23.483646408839 | dexamethasone | MK 125; NSC 34521 | steroids hormones glucocorticoid agonist receptors inflammation genes expression anti-inflammatory antiinflammatory anti inflammatory 8054-59-9 137098-19-2 906362-70-7 906422-84-2 1050677-47-8 adexone aeroseb-Dex aphtasolon aphthasolone azium calonat corsone cortisumman decacort decaderm decadron A decalix decasone dekacort dekort delipos deltafluorene dergramin deronil desadrene desameton deseronil dexa-cortidelt dexa-mamallet dexa-scheroson dexa-sine dexacort dexacortal dexacortin dexadeltone dexafarma dexalona dexaltin dexameth dexamethasone alcohol dexamonozon dexapolcort dexapos dexaprol dexason dexasone dexinoral dexmethsone dexone dexonium dextelan dinomon diodex etacortilen fluormone fluorocort gammacorten gentalipos HL-dex hexadecadrol hexadrol isopto-dex lokalison F loverine luxazone MK-125 MK125 maxidex millicorten NSC-34521 NSC34521 oradexon pet-derm III posurdex prednisolon F prednisolone superprednol surodex visumetazone | 23.483646408839 | ||
| 10010948 |
DL- |
- | ≥98% |
|
2008-08-19 | 17.522989249343 | dl-propargyl-glycine-hydrochloride | PAG | H2S gasotransmitter inhibitor inhibits inhibition CSE vasodilation inflammation propargylglycine | 17.522989249343 | ||
| 9090310 | Docosahexaenoic Acid ethyl ester | 1020718-25-5 | ≥98% |
|
2009-01-15 | 68.145290055248 | docosahexaenoic-acid-ethyl-ester | DHA ethyl ester; Cervonic Acid ethyl ester | fish oils anti-inflammatory antiiflammatory cardiovascular polyunsaturated fatty acids PUFAs DHAs neural tissues retina brain learning diet nutrition oxidation vision liver function muscle tone competitive inhibitors inhibits inhibition metabolism | 68.145290055248 | ||
| 10460 | Doramapimod | 285983-48-4 | ≥98% |
|
2011-06-02 | 19.724613259668 | doramapimod | BIRB-796 | p38 MAPKs inflammation TNFα TNF-α TNF α TNFalpha TNF-alpha TNF alpha JNKs inhibitors proteins kinases tumors necrosis factors LPS THP.1 cells THP1 BIRB796 BIRB 796 mitogen activated mitogen-activated proinflammatory cytokins interleukin-1 IL IL-1 interleukin 1 | 19.724613259668 | ||
| 101640 | DP1 Receptor Polyclonal Antibody | - |
|
2004-10-22 | 22.917776243093 | dp1-receptor-polyclonal-antibody | Prostaglandin D2 Receptor 1; PGD2 Receptor 1 | isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting | 22.917776243093 | |||
| 10007963 |
E- |
66701-25-5 | ≥98% |
|
2009-11-12 | 28.585893186004 | e-64 | inhibitors cysteine proteases cathepsins papain calpain irreversible inhibition inhibited E64 E 64 | 28.585893186004 | |||
| 10007964 |
E- |
76684-89-4 | ≥98% |
|
2006-08-02 | 27.459705340700 | e-64c | EP 475; Loxistatin Acid; NSC 694279 | E-64 cysteine protease cell cycle inhibitor E-64d | 27.459705340700 | ||
| 10111 | EA4 | - | ≥95% |
|
2005-10-12 | 11.138498242089 | ea4 | phospholipase A2 cPLA2 RBCs red blood cells CYP1A1 CYP1B1 cytochromes P450 cytosolic cow bovine human group IV quinones derivatives inhibits inhibition rPLA2 ionophore-induced ionophores arachidonic acids release calcium Ca2+-dependent Ca+2 mammalian mRNA proteins mouse murine hepatoma Hepa-1c1c7 MCF-7 Hep-G2 HL-60 | 11.138498242089 | |||
| 10005056 |
Eicosapentaenoic Acid- |
145191-14-6 | ≥99% deuterated forms (d1-d5) |
|
2005-08-30 | 291.556055248619 | eicosapentaenoic-acid-d5 | EPA-d5; Timnodonic Acid-d5 | GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory | 291.556055248619 | ||
| 9000295 | Eicosapentaenoic Acid methyl ester | 2734-47-6 | ≥98% |
|
2011-10-07 | 53.386786372007 | eicosapentaenoic-acid-methyl-ester | EPA methyl ester | vascular cardiovascular diseases immunity resolvins autoimmunity nephritis glomerulonephritis inflammation anti-inflammatory resolutions prodrugs antiinflammatory anti inflammatory immune physiology resolvins pro-drugs hydrolyzed esterases cells EPAs | 53.386786372007 | ||
| 10964 | Eicosapentaenoyl Ethanolamide | 109001-03-8 | ≥98% |
|
2011-06-22 | 57.375516969219 | eicosapentaenoyl-ethanolamide | EPEA | cannabinoids CBSs endocannabinoids forensic sciences signals signaling N-acylethanolamide N-acylethanolamine NAE dietary restrictions lifespans TOR nematodes eicosapentaenoic acids inflammation anti-inflammatory | 57.375516969219 | ||
| 10569 | Ellagic Acid | 476-66-4 | ≥95% |
|
2010-10-13 | 8.133806015960 | ellagic-acid | Lagistase; TBBD; Gallogen | polyphenols, antioxidants, cancers inflammation cytochrome P450s CYP450 epigenetics genes expression histones modifications alizarin yellow G 91006 elagostasine 77415-21-5 124590-32-5 PRMTs inflammatory anti-carcinogenic anti-mutagenic organ-preserving antimutagenic antiinflammatory Acid Benzoaric Benzoaric Acid Acid Ellagic Ellagic Acid | 8.133806015960 | ||
| 10477 | EP2 Receptor Polyclonal PE Antibody | - | 2010-07-07 | 30.416372007366 | ep2-receptor-polyclonal-pe-antibody | Prostaglandin E2 Receptor 2; PGE2 Receptor 2 | R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons | 30.416372007366 | ||||
| 600340 | EP2 Receptor (rat) STEP Reporter Assay Kit (Luminescence) Exclusive | - |
|
✓ | 2010-09-20 | 33.266108041743 | ep2-receptor-rat-step-reporter-assay-kit-luminescence | Prostaglandin E2 Receptor 2; PGE2 Receptor 2 | prostaglandins E2 PGE2 prostanoids G protein-coupled receptors GPCRs EP1 EP3 EP4 signal transduction tissues regulation cells mediates cAMP cyclic messenger pathways mucosal protection gastrointestinal secretions motility immunity inflammation mice mouse murine tumors cancers cancer-associated immunodeficiency dendritic-cell differentiation in vitro neuroprotective NMDA toxicity oxygen glucose deprivation agonists antagonists therapeutics Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening | 33.266108041743 | ||
| 600410 | EP4 Receptor (rat) STEP Plate Assay Kit (cAMP method) | - |
|
2011-06-28 | 6.434866482504 | ep4-receptor-rat-step-plate-assay-kit-camp-method | cell-based assays cells CBAs kits measures measurements prostaglandins E2 PGE2 prostanoids G protein-coupled receptors proteins GPCRs EP1 EP2 EP3 signals transductions mechanisms tissues localizations regulation expression intestines lungs kidneys thymus uterus brains cyclics AMP adenosines monophosphates pathways phosphatidylinositols 3-kinases G1 smooth muscles relaxation gastric secretions intestinal epithelial transportation adrenal aldosterone uterine immunity inflammation human colon cancers colorectal carcinogenesis in vivo neuroprotective excitotoxic injury injuries agonists antagonists therapeutics diseases surface transfections and expression protocols transient technology technologies University of Michigan UM U of M Originus, Inc. USPT United States patents 6897067 6902933 7056741 DNA deoxyribonucleic recombinant proteins cells receptor-mediated endocytosis solution-phase efficiency multiple plasmids constructs intracellular | 6.434866482504 | ||||
| 10008610 | Epoxy Fluor 7 Exclusive | 863223-43-2 | ≥98% |
|
✓ | 2006-08-30 | 15.257403314917 | epoxy-fluor-7 | epoxides hydrolases fluorescence enzymes activity inhibition screening hypertension inflammation sepsis EETs DHETs EpETrEs DiHETrEs fluorescent SEH soluble endocrinology | 15.257403314917 | ||
| 10009798 |
EX- |
49843-98-3 | ≥98% |
|
2009-10-23 | 28.387292817679 | ex-527 | sirtuins SIRT1 histones deacetylase HDAC energy metabolism inflammation inhibitors p53 DNA damage 848193-68-0 848193-69-1 | 28.387292817679 | |||
| 10009549 | FABP4 (human recombinant) | - | ≥90% |
|
2007-06-15 | 16.343603909902 | fabp4-human-recombinant | A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein | cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology | 16.343603909902 | ||
| 9001068 | FABP4 (human recombinant) FITC conjugated | - | ≥95% |
|
2011-08-23 | 6.631610102604 | fabp4-human-recombinant-fitc-conjugated | ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 | fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 | 6.631610102604 | ||
| 10010463 | FABP4 (human recombinant) Western Ready Control | - | 2007-10-23 | 3.441008287292 | fabp4-human-recombinant-western-ready-control | Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP | fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting | 3.441008287292 | ||||
| 10005191 | FABP4 (mouse recombinant) | - | ≥95% | 2005-07-27 | 6.236795580110 | fabp4-mouse-recombinant | Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP | protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology | 6.236795580110 | |||
| 10009676 | FABP4 (mouse recombinant) Western Ready Control | - | 2007-04-30 | 2.515782688766 | fabp4-mouse-recombinant-western-ready-control | ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP | fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis | 2.515782688766 | ||||
| 10610 |
F- |
- | ≥95% |
|
✓ | 2011-09-23 | 28.482596685083 | f-amidine-trifluoroacetate-salt | proteins arginine deiminase 4 PAD4 cancers arthritis inhibitors histones genes expression cysteine PAD1 PAD3 cytotoxic HL-60 MCF7 HT-29 877617-46-4 PADs PAD-1 PAD-3 PAD-4 peptidyl arginine | 28.482596685083 | ||
| 13563 | FIPI Exclusive | 939055-18-2 | ≥98% |
|
✓ | 2010-03-24 | 32.235558011049 | fipi | 5-Fluoro-2-Indolyl des-Chlorohalopemide | Phospholipases D PLD phosphatidic acids PA Ras activation cells spreading stress fiber formation chemotaxis membrane vesicles trafficking halopemide inhibitors inhibits inhibition PLD1 PLD2 F-actin cytoskeletons inflammation arthritis Pharmascience Brand of Domperidone Maleate Stadapharm Brand of Domperidone Maleate Ratiopharm Brand of Domperidone Maleate Taxandria Brand of Domperidone Maleate Novopharm Brand of Domperidone Maleate Nu-Pharm Brand of Domperidone Maleate Nu Pharm Brand of Domperidone Maleate Apotex Brand of Domperidone Maleate Hexal Brand of Domperidone Maleate Aliud Brand of Domperidone Maleate Teva Brand of Domperidone Maleate Pierre Fabre Brand of Domperidone Gry Brand of Domperidone Maleate Rottapharm Brand of Domperidone Monohydrochloride, Domperidone Domperidone Monohydrochloride Janssen Brand of Domperidone Domperidone Maleate (1:1) Maleate, Domperidone Domperidone Maleate Gamir Domperidona Stada Domperidon ratio-Domperidone ratio Domperidone Hexal Domperidon Domperidona Gamir Novo-Domperidone Novo Domperidone Domperidon Stada Domperidon Hexal PMS-Domperidone PMS Domperidone Domperidon-TEVA Domperidon TEVA Apo-Domperidone Apo Domperidone Nu-Domperidone Nu Domperidone Domperidon AL Domperidone Gastrocure Domperidon R-33,812 Nauzelin Motilium R-33812 R33,812 Péridys Domidon R33812 | 32.235558011049 | |
| 10039 | FR122047 (hydrate) | - | ≥98% |
|
13.770676795580 | fr122047-hydrate | 130717-51-0 FR-122047 cyclooxygenases COX-1 inhibitors hydrates hydrochlorides COX1 PGHS1 PGHS-1 prostaglandin synthases inhibition inhibits selective selectivity platelet aggregation antiinflammatory atherosclerosis | 13.770676795580 | ||||
| 13254 |
FTY720 phenoxy- |
- | ≥95% |
|
✓ | 2009-10-28 | 71.479212707182 | fty720-phenoxy-biotin | sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 biotins biotinylated biotinamide | 71.479212707182 | ||
| 10008346 | Gabapentin | 60142-96-3 | ≥98% |
|
2006-04-20 | 3.915138121546 | gabapentin | Neurontin® | antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry | 3.915138121546 | ||
| 10566 | Garcinol | 78824-30-3 | ≥95% |
|
2011-10-25 | 9.634610820401 | garcinol | Camboginol | inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics | 9.634610820401 | ||
| 10010622 | Genipin | 6902-77-8 | ≥98% |
|
2008-05-09 | 144.961325966851 | genipin | (+)-Genipin | obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity | 144.961325966851 | ||
| 10011356 |
Glycerophospho- |
100575-09-5 | ≥98% |
|
✓ | 2009-03-12 | 7.585174953959 | glycerophospho-n-palmitoyl-ethanolamine | GP-NPEA; GP-NAE | cannabinoids neurotransmitter neurochemistry neuroscience fatty acids amides hydrolase FAAHs palmitoyl ethanolamides inflammation anti-inflammatory C16:0 CBS NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic | 7.585174953959 | |
| 13127 | GW 4869 | 6823-69-4 | ≥90% |
|
2009-06-10 | 53.862989564150 | gw-4869 | inhibitors sphingomyelin sphingomyelinase neutral acidic TNF-α ceramides cells death GW4869 gw-4869 | 53.862989564150 | |||
| 10009162 | GW 627368X Exclusive | 439288-66-1 | ≥96% |
|
✓ | 2007-05-14 | 32.455359116022 | gw-627368x | EP4 receptor antagonist TP prostanoid prostaglandin platelets U-46619 aggregation PGE2 EP1 EP2 EP3 GW627368X GW-627368X | 32.455359116022 | ||
| 10010372 | GW 842166X | 666260-75-9 | ≥98% |
|
2008-05-23 | 34.145428176795 | gw-842166x | inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic | 34.145428176795 | |||
| 10010410 | GW 848687X | 612831-24-0 | ≥98% |
|
2009-11-25 | 16.795624309392 | gw-848687x | Receptors EP1 PGE2 vasoconstriction bronchoconstriction hyperalgesia allodynia gastric protection relief hyperthermia sleep antagonists thromboxanes TP inflammation arthritis pain inflammatory GW848687X GW-848687X | 16.795624309392 | |||
| 13345 | GYY 4137 Exclusive | 106740-09-4 | ≥95% |
|
✓ | 2009-07-31 | 73.799575541861 | gyy-4137 | hydrogen sulfides H2S gaseous mediators nitric oxides NOs donors vasodilator antihypertensive anti-hypertensive rats spontaneously hypertensive hypertension models endotoxic shock TNF-α TNFα TNF α TNF-a TNFa IL-1b IL1b IL-1β IL1β IL-6 IL6 NFkB NF-kB NF-κB NFκB iNOS COX-2 COX2 PGE2 110-91-8 106740-08-3 | 73.799575541861 | ||
| 10009465 | HDAC6 (human recombinant) | - | ≥80% | 2007-06-14 | 22.816166595834 | hdac6-human-recombinant | GenBank Accession No. BC069243; Histone Deacetylase 6 | HDAC 6 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways proteins Class II cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers N-terminal N-terminus GST-tagged Sf9 active | 22.816166595834 | |||
| 10009466 | HDAC9 (human recombinant) | - | ≥95% | 2007-06-14 | 16.569378453038 | hdac9-human-recombinant | GenBank Accession No. NM 178423; Histone Deacetylase 9 | histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active | 16.569378453038 | |||
| 11622 | Heneicosapentaenoic Acid methyl ester Exclusive New | 65919-53-1 | ≥98% |
|
✓ | 2012-04-23 | 101.111111111110 | heneicosapentaenoic-acid-methyl-ester | HPA methyl ester | fatty acids EPA DHA arachidonic linoleic PGH synthases 5-LO prodrugs 5-LOX LO LOX prostaglandins PGs HPA Bryopsis pennata Lamouroux green algae fish oils eicosapentaenoic docosahexaenoic phospholipids 5-lipoxygenases 5 lipoxygenases | 101.111111111110 | |
| 10006809 |
Heptanoyl thio- |
- | ≥98% |
|
2005-10-05 | 4.510911602210 | heptanoyl-thio-pc | sPLA2s substrates colorimetrics phospholipases thioesters analogs glycerophospholipids Ellman's reagent measurements activity diheptanoyl thio-PC ether-linked saturated C16 moiety sn-1 position modifications resistant PLA1 pig porcine pancreatic bee venom | 4.510911602210 | |||
| 11512 | HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New | - |
|
2012-01-16 | 0E-12 | hmgb1-monoclonal-antibody-clone-img19n10b7 | High Mobility Group Protein B1; HMG1 | high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB | 0E-12 | |||
| 11514 | HMGB1 Monoclonal Antibody (Clone IMG19N12A1) | - |
|
0E-12 | hmgb1-monoclonal-antibody-clone-img19n12a1 | High Mobility Group Protein B1; HMG1 | high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting | 0E-12 | ||||
| 11513 | HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New | - |
|
2012-01-16 | 0E-12 | hmgb1-monoclonal-antibody-clone-img19n15f4 | HMG1; High Mobility Group Protein B1 | high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC | 0E-12 | |||
| 11515 |
HMGB1 Polyclonal Antibody (aa 100- |
- |
|
2012-01-20 | 0E-12 | hmgb1-polyclonal-antibody-aa-100-150 | HMG1; High Mobility Group Protein B1 | high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC | 0E-12 | |||
| 11516 |
HMGB1 Polyclonal Antibody (aa 25- |
- |
|
2012-01-30 | 0E-12 | hmgb1-polyclonal-antibody-aa-25-75 | HMG1; High Mobility Group Protein B1 | high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting | 0E-12 | |||
| 10888 | HZ52 | 1077626-51-7 | ≥98% |
|
2011-09-30 | 17.110718232043 | hz52 | inhibitors inhibits inhibition 5-LO 5 LO 5LO leukotrienes LTBs LTB4 LTs leukocytes neutrophils inflammation shock HZ-52 HZ 52 | 17.110718232043 | |||
| 13930 | IKKγ Monoclonal Antibody (Clone 46B844) | - |
|
2010-10-20 | 15.758195211786 | ikk-monoclonal-antibody-clone-46b844 | NF-κB Essential Modulator; NEMO; IKK3 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ IKKg IKKγ IKKgamma IKK.gamma. IKK-g IKK-γ IKK-gamma IKK-.gamma. IKK g γ .gamma. gamma cytoplasm inhibitory inhibits inhibitions proteins mask nuclear localization signals translocation nucleus tumors necrosis factors cytokines phosphorylation degradation dimers translocates genes autoregulated auto regulated auto-regulated complex essentials modulators t-cells t cells tcells leukemia virus types 1 one taxes oncoprotein key molecule adapter onco-protein onco oncoprotein signalling signalin western blots immunoblotting WB blotting flow cytometry FC intracellular | 15.758195211786 | |||
| 13931 | IKKγ Monoclonal Antibody (Clone 72C627) | - |
|
2010-11-08 | 15.758195211786 | ikk-monoclonal-antibody-clone-72c627 | NF-κB Essential Modulator; NEMO; IKK3 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ IKKg IKKγ IKKgamma IKK.gamma. IKK-g IKK-γ IKK-gamma IKK-.gamma. IKK g γ .gamma. gamma cytoplasm inhibitory inhibits inhibitions proteins mask nuclear localization signals translocation nucleus tumors necrosis factors cytokines phosphorylation degradation dimers translocates genes autoregulated auto regulated auto-regulated complex essentials modulators t-cells t cells tcells leukemia virus types 1 one taxes oncoprotein key molecule adapter onco-protein onco oncoprotein signalling signalin western blots WB blotting | 15.758195211786 | |||
| 13929 | IKKε Monoclonal Antibody (Clone 72B587) | - |
|
2010-10-20 | 15.758195211786 | ikk-monoclonal-antibody-clone-72b587 | TBK1; IKKi | antibodies IKKe IKKε IKK e ε IKK-e IKK-ε IKKepsilon IKK epsilon IKK-epsilon IKK.epsilon. .epsilon. IKK-.epsilon. IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ cytoplasm inhibitory inhibits inhibition proteins nuclear localization signals nucleus stimuli tumor necrosis factors sytokines phosphorylation degradation dimers subtracive hybridization technique novel kinases LPS mRNA levels mouse murine macrophage cells lines overexpression wild types phosphorylates Ser32 Ser36 Ser-32 Ser-36 Ser 32 36 | 15.758195211786 | |||
| 13928 | IKKε Polyclonal Antibody | - |
|
2010-10-20 | 15.758195211786 | ikk-polyclonal-antibody | IKKi | antibodies IKKe IKKε IKK e ε IKK-e IKK-ε IKKepsilon IKK epsilon IKK-epsilon IKK.epsilon. .epsilon. IKK-.epsilon. IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ cytoplasm inhibitory inhibits inhibition proteins nuclear localization signals nucleus stimuli tumor necrosis factors sytokines phosphorylation degradation dimers subtracive hybridization technique novel kinases LPS mRNA levels mouse murine macrophage cells lines overexpression wild types phosphorylates Ser32 Ser36 Ser-32 Ser-36 Ser 32 36 | 15.758195211786 | |||
| 10809 |
Interleukin- |
- |
|
2011-06-03 | 2.646408839779 | interleukin-33-human-monoclonal-antibody-clone-il33305b | IL-1F11; IL-33; NF-HEV | antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV | 2.646408839779 | |||
| 10811 |
Interleukin- |
- |
|
2011-06-02 | 1.323204419889 | interleukin-33-monoclonal-antibody-clone-il33026b | NF-HEV; IL-33; IL-1F11 | antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV | 1.323204419889 | |||
| 10810 |
Interleukin- |
- |
|
2011-06-02 | 1.323204419889 | interleukin-33-monoclonal-antibody-clone-il333068a | IL-33; NF-HEV; IL-1F11 | antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay 1F11 IL1F11 interleukin 33 NFHEV NF HEV | 1.323204419889 | |||
| 10005518 | IP Receptor (human) Polyclonal Antibody | - | 2004-10-21 | 25.489591774094 | ip-receptor-human-polyclonal-antibody | Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor | antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis | 25.489591774094 | ||||
| 13843 |
IRAK- |
- |
|
2010-11-11 | 0.866298342541 | irak-1-polyclonal-antibody | Interleukin-1 Receptor-Associated Kinase 1 | NF-kB NF-κB NFkB NFκB NF kB NFκB NF-kappaB kappaB NFkappaB NF.kappa.B NF-.kappa.B .kappa.B nuclear factor κB serine threonine serine/threonine IL-1 IL1 IL 1 receptors signaling cascase activation members novel cytokines IL-18 IL18 18 IGIF antibodies western blots blotting immunoblotting WB IP immunoprecipatation IRAK-1 | 0.866298342541 | |||
| 13844 |
IRAK- |
- |
|
2010-11-18 | 0.433149171270 | irak-2-polyclonal-antibody | Interleukin-1 Receptor-Associated Kinase-Like 2 | NF-kB NF-κB NFkB NFκB NF kB NFκB NF-kappaB kappaB NFkappaB NF.kappa.B NF-.kappa.B .kappa.B nuclear factor κB serine threonine serine/threonine IL-1 IL1 IL 1 antibodies western blots blotting immunoblotting WB IL-1RI signaling cascade activation IRAK-2 IRAKs 2 pelle proteins kinases drosophila cytokine oligonucleotides inhibits inhibition IL-18 IL18 anti-sense antisense AP-1 AP1 APs 1 IRAK2 | 0.433149171270 | |||
| 13845 |
IRAK- |
- |
|
2010-11-18 | 0.511740331491 | irak-4-polyclonal-antibody | Interleukin-1 Receptor-Associated Kinase-Like 4 | NF-kB NF-κB NFkB NFκB NF kB NFκB NF-kappaB kappaB NFkappaB NF.kappa.B NF-.kappa.B .kappa.B nuclear factor κB antibodies toll-like toll like receptors interleukin-1 IL-1 IL1 IL TLRs mammal transmembranes trans membranes IRAKs TRAF6 TRAF-6 TRAFs 6 MyD88 MAPK pathways LPS activation murine viral bacterial antibodies western blots WB immunoblotting blotting immunoprecipitation IP IRAK4 | 0.511740331491 | |||
| 10739 | Isoliquiritigenin | 961-29-5 | ≥98% |
|
2011-04-01 | 50.434276243093 | isoliquiritigenin | ISL; GU 17 | antioxidants flavonoids chemoprevention quinones reductase-1 reductase1 hepatoprotection hepatoma cells flavanoids | 50.434276243093 | ||
| 13925 | IκBα (cleavage specific) Monoclonal Antibody (Clone 5D1623) | - |
|
2010-09-29 | 9.454917127071 | i-b-cleavage-specific-monoclonal-antibody-clone-5d1623 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular immunoblotting NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target cleaved caspases caspase-3 3 apoptosis amino-terminal amino terminals truncated DN-IκBα DNIκBα DN ΔN-IκBα ΔN .DELTA.N DELTAN .DELTA.N-IκBα DELTAN-IκBα DELTA-N .DELTA.-N degradation inducers dominant inhibitory molecule suppresses activity inflammation | 9.454917127071 | ||||
| 13922 |
IκBα Monoclonal Antibody - |
- | 2010-09-27 | 12.893068809643 | i-b-monoclonal-antibody-biotin-clone-6a920 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular immunoblotting NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target ELISA biotinlated biotins | 12.893068809643 | |||||
| 13918 | IκBα Monoclonal Antibody (Clone 6A920) | - |
|
2010-09-23 | 12.893068809643 | i-b-monoclonal-antibody-clone-6a920 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α flow cytometry FC intracellular immunohistochemistry IHC paraffin-embedded sections paraffin embedded immunoprecipitation IP western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target | 12.893068809643 | ||||
| 13924 |
IκBα (Phospho- |
- | 2010-09-29 | 0E-12 | i-b-phospho-ser32-36-monoclonal-antibody-biotin-clone-39a1413 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser EIA ELISA biotins biotinylated inflammation genes regulation signal transduction | 0E-12 | |||||
| 13923 |
IκBα (Phospho- |
- |
|
2010-09-29 | 12.893068809643 | i-b-phospho-ser32-36-monoclonal-antibody-clone-39a1413 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target immunoprecipitation IP serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser genes regulation inflammation signal transduction | 12.893068809643 | ||||
| 13921 | IκBα Polyclonal Antibody | - |
|
2010-09-23 | 0E-12 | i-b-polyclonal-antibody | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target | 0E-12 | ||||
| 13919 |
IκBα Polyclonal Antibody (aa 34- |
- |
|
2010-09-23 | 12.893068809643 | i-b-polyclonal-antibody-aa-34-48 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB antibodies IκBα IkBa IκBa IkBα IκB-α IκB α slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target | 12.893068809643 | ||||
| 9000059 |
(±)- |
39924-52-2 | ≥95% (mixture of isomers) |
|
2009-04-01 | 6.891955801105 | -jasmonic-acid-methyl-ester | (±)-Methyl Jasmonate | cancers plants apoptosis survival inflammation hexokinase jasmonic acids jasmonates stress hormones proteins inhibitors inhibition inhibited mitochondrial hexokinase anti-inflammatory | 6.891955801105 | ||
| 10011925 |
JNJ- |
459168-41-3 | ≥98% |
|
2011-02-24 | 0.482320441989 | jnj-7777120 | histamines H4 receptors antagonists inflammation Piperazines | 0.482320441989 | |||
| 10009018 | JWH 015 | 155471-08-2 | ≥98% |
|
2006-10-05 | 63.861233412638 | jwh-015 | agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic JWH15 JWH-15 JWH 15 | 63.861233412638 | |||
| 10660 |
JWH 015- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2011-02-21 | 44.219281767956 | jwh-015-d7 | agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 | 44.219281767956 | ||
| 9001148 | Ketorolac New | 74103-06-3 | ≥98% |
|
2012-01-12 | 12.447457304307 | ketorolac | Sprix®; Acular PF®; RS 37619; Acular LS® | analgesic NSAIDs COX inhibition inhibits inhibitors ocular pain inflammation PGE2 non steroidal anti-inflammatory antiinflammatory drugs heteroaryl acetic acids derivatives cyclooxygenase opthalmalic solutions ocular COX-1 COX-2 COX1 COX2 racemic 66635-83-4 | 12.447457304307 | ||
| 10011565 |
L- |
147776-06-5 | ≥98% |
|
2009-02-26 | 47.734990791896 | l-161-982 | PGEs PGE2 EPs EP4 receptors antagonist bone formation inflammation cells proliferation colon cancers L161982 L-161982 | 47.734990791896 | |||
| 10007712 |
L- |
634193-54-7 | ≥98% |
|
✓ | 2010-05-07 | 42.970236779794 | l-902-688 | PGE2 bones growth EP4 agonists hyperalgesia vasodialation | 42.970236779794 | ||
| 10010329 | Lavendustin C | 125697-93-0 | ≥98% |
|
2008-07-08 | 11.503353591160 | lavendustin-c | HDBA; NSC 666251 | EGFR kinases tyrosine pp60c-src pp60csrc CamKII SOD neutrophil activation erbstatin inhibitor inhibits inhibition Lavendustin-C | 11.503353591160 | ||
| 10006148 | Leelamine | 1446-61-3 | >98% |
|
2006-05-10 | 0.274861878453 | leelamine | Dehydroabietylamine | inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic | 0.274861878453 | ||
| 10008614 | Leelamine (hydrochloride) | - | ≥98% |
|
2006-05-10 | 0.154696132596 | leelamine-hydrochloride | Dehydroabietylamine | inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic | 0.154696132596 | ||
| 10007817 | Leukotriene A4 Hydrolase (human recombinant) | - | ≥90% | 2005-12-14 | 275.808100344092 | leukotriene-a4-hydrolase-human-recombinant | LTA4H | leukotrienes bifunctional zinc metalloenzymes converts LTB4 neutrophils chemoattractants hydrolases activity anion-dependent aminopeptidases drugs leukocytes infiltration inflammation E. coli epoxides atherosclerosis active | 275.808100344092 | |||
| 20110 | Leukotriene B4 | 71160-24-2 | ≥97% |
|
180.943799155021 | leukotriene-b4 | LTB4 | leukotrienes LTB4 inflammation chemotaxis atherosclerosis | 180.943799155021 | |||
| 20114 |
Leukotriene B4- |
89596-43-0 | ≥95% |
|
2009-03-05 | 429.324088397790 | leukotriene-b4-3-aminopropylamide | LTB4-3-aminopropylamide | LTB LTB4 BLTs BLT1 BLT2 inflammation immunology | 429.324088397790 | ||
| 20112 | Leukotriene B4 Ethanolamide | - | >97% |
|
33.184814522494 | leukotriene-b4-ethanolamide | LTB4-EA | BLTR2 receptors leukotrienes LTB4 ethanolamides cannabinoids anandamides ligands BLT2 neuroscience ethanolamines | 33.184814522494 | |||
| 10007240 | Leukotriene B4 Lipid Maps MS Standard | 71160-24-2 | ≥97% |
|
2009-01-14 | 29.751524861878 | leukotriene-b4-lipid-maps-ms-standard | LTB4 | leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards | 29.751524861878 | ||
| 10006198 |
Leukotriene C4- |
- | ≥99% deuterated forms (d1-d5) |
|
2007-04-11 | 154.699889502763 | leukotriene-c4-d5 | LTC4-d5 | cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry | 154.699889502763 | ||
| 10007692 | Licofelone | 156897-06-2 | ≥98% |
|
2006-04-03 | 42.057740945364 | licofelone | ML 3000 | inibits inhibitors inhibition lipoxygenases LOX cyclooxygenases COX osteoarthritic OA synovial explants arachidonic acids AA shunting interleukins 1.beta. IL-1b synthesis prostaglandins PGE2 leukotrienes LTB4 lipoxins LPS cells non-steroidal anti-inflammatory drugs NSAIDS gastric mucosa parietal acid-secretory mechanisms ML3000 | 42.057740945364 | ||
| 10011453 | Lipoxin A5 Exclusive | 110657-98-2 | ≥95% |
|
✓ | 2008-11-17 | 52.935755064456 | lipoxin-a5 | LXA5 | EPAs LXA4 LXB4 smooth muscle contraction lipoxins vasodilatory leukocytes pulmonary parenchymal LXAs | 52.935755064456 | |
| 10010785 |
(±)- |
6493-06-7 | ≥98% |
|
2009-09-18 | 21.729350828728 | -lisofylline | CT-1501R; BL 194; LSF | pentoxifylline phosphatidic acids shock sepsis antiinflammatory anti-inflammatory insulin diabetes IL-12 IL-12 inhibits inhibitions inhibitors IFN-γ IFNγ β-cell cell 39476-38-5 151852-35-3 | 21.729350828728 | ||
| 700570 |
L- |
- |
|
✓ | 2011-05-31 | 249.451887176504 | l-theanine-fluorometric-assay-kit | 5-N-ethyl-Glutamine; Glutamic Acid γ-ethyl amide; γ-ethylamino-L-Glutamic Acid; γ-Glutamylethylamide | kits assays measures measurements glutamines amino acids aa Camellia sinensis C. sinensis green teas japonica sasanqua mushrooms Xerocomus badius X. badius water-solubles non-proteins plants leaves umami humans immune systems .gamma..delta. gammadelta γδ T cells T-cells infection-fighting infections antigens ethylamine renal metabolites brains .alpha.-waves alpha-waves α-waves alertness schizophrenia neuroprotective effects glutamates receptors N-methyl-D-aspartate NMDA calcium Ca Ca2+ intracellular animals anthracyclines hypertensives rats antihypertensives blood pressures dopamines norepinephrines serotonins | 249.451887176504 | ||
| 500260 | Luminex® Leukotriene B4 Kit | - |
|
2008-11-12 | 61.059580110497 | luminex-leukotriene-b4-kit | Luminex® LTB4 Kit | leukotrienes arachidonic acids 5-lipoxygenases LTA4 hydrolases mediator inflammation leukocytes aggregation stimulation stimulates fluxes lysosomes lysosomal kits enzymes release superoxides anions production chemotaxis chemokinesis subnanomolar human neutrophils degranulation plasma hepatocytes 20-hydroxy 20-carboxy NADPH-dependent nicotinamides adenines dinucleotides phosphates CYP450 cytochromes b-oxidation .beta.-oxidation beta-oxidation w-end omega-end .omega.-end w-carboxy omega-carboxy .omega.-carboxy dinor tetranor urine culture media sample matrices EIAs ELISAs enzyme immunoassays assays | 61.059580110497 | |||
| 10007502 | Luminex® Thromboxane B2 Kit | - |
|
2009-07-13 | 37.424419889502 | luminex-thromboxane-b2-kit | Luminex® TXB2 Kit | thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays | 37.424419889502 | |||
| 11215 | Lupeol New | 545-47-1 | ≥98% |
|
2012-02-15 | 22.361170100521 | lupeol | NSC 90487; Monogynol B; Fagarasterol; β-Viscol; Lupenol; Clerodol | AC-1371 AC1371 AC 1371 132473-92-8 200123-55-3 fagarsterol dietary triterpenes anti-inflammatory anticarcinogenic antimutagenic antimaralia fruits vegetables medicinal plants antimalarial cells carcinoma cancers SMMC7721 SMMC-7721 SMMC 7721 HepG2 melanoma mel928 mel-928 mel 928 mel1241 mel-1241 mel 1241 blood pressure strokes hypertension rats genes cholesterol synthesis neutrophils monogynol B NSC-90487 NSC90487 beta-viscol b-viscol | 22.361170100521 | ||
| 10010024 | LY223982 Exclusive | 117423-74-2 | ≥98% |
|
✓ | 2008-07-24 | 2.106629834254 | ly223982 | SKF 107324; CGS 23131 | LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis leukotriene B4 fatty acids 5-LO 5LO CGS23131 SKF107234 | 2.106629834254 | |
| 10009768 | LY293111 Exclusive | 161172-51-6 | ≥98% |
|
✓ | 2009-02-09 | 62.413743093923 | ly293111 | Etalocib; VML 295 | LTBs LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis pancreatic cancers | 62.413743093923 | |
| 10172 |
Lyso- |
17364-16-8 | >98% |
|
2004-03-02 | 15.121431441487 | lyso-pc | lysopc signals transduction pathways G2A receptors lipids phosphatidylcholines phospholipases PLAs hydrolysis lysophosphatidic acid lysophosphatidyl choline LPA | 15.121431441487 | |||
| 10010497 | Manumycin A | 52665-74-4 | ≥98% |
|
2008-06-25 | 16.571464088398 | manumycin-a | UCF 1C; NSC 622141 | farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB | 16.571464088398 | ||
| 13320 |
MCI- |
89-25-8 | ≥98% |
|
2010-07-15 | 26.449897395422 | mci-186 | NSC 2629; Edaravone | free radical scavengers inhibitors inhibits inhibition ischemia-reperfusion injury transplants infections traumatic brain injury injuries Ketoquinolines Oxoquinolines Quinolinones Quinolones strokes reactive oxygen species apoptosis Norantipyrine Norphenazone Radicut 206195-95-1 115566-83-1 72134-66-8 62495-97-0 52224-17-6 12235-58-4 methylphenylpyrazolone NSC 26139 NSC 12 Edarabone | 26.449897395422 | ||
| 10639 | MDA 77 Exclusive | 1103774-21-5 | ≥98% |
|
✓ | 2011-05-16 | 2.672099447514 | mda-77 | CB2 inverse agonists inflammation pain CB1 CBs cannabinoids peripheral MDA77 MDA-77 in vivo binds binding assay | 2.672099447514 | ||
| 13847 | MEK2 Polyclonal Antibody | - |
|
2010-11-18 | 0E-12 | mek2-polyclonal-antibody | MAPKK2; MAP Kinase Kinase 2; Dual Specificity MAP Kinase Kinase 2; MAP Kinase/ERK Kinase 2 | MEKs MEK-2 MEK2 MAPKs kinases MAP ERKs phosphorylation antibodies serine cytokines growth factors tranduction mitogenic signals western blots blotting immunoblotting | 0E-12 | |||
| 13848 | MEKK2 Polyclonal Antibody | - |
|
2010-12-21 | 0E-12 | mekk2-polyclonal-antibody | MAP Kinase/ERK Kinase Kinase 2; Dual Specificity MAP Kinase Kinase Kinase 2; MAP Kinase Kinase Kinase 2; MAP3K2; MAPKKK2 | MEKs MEK-2 MEK 2 MAPKs kinases MAPs mitogen-activated mitogen activated proteins signaling pathway phosphorylate IkB I.kappa.B IkappaB IκB NF-κB NF-kappaB NF-.kappa.B NFκB NF.kappa.B NFkB T-cells T cells cytokine genes expressions mast cells epidermal growth factor EGRs fibroblast growth factor-2 factor 2 FGF-2 FGF2 FGFs 2 signals rheumatoid arthritis LPS-TLR4 LPS TLR4 TLR-4 TLR 4 ligands phosphorylation western blots blotting immunoblotting WB immunohistochemistry IHC MAP kinase kinase kinase | 0E-12 | |||
| 600160 | Methionine Sulfoxide Immunoblotting Kit | - |
|
2009-12-17 | 234.812994475138 | methionine-sulfoxide-immunoblotting-kit | MetO Immunoblotting Kit | proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 | 234.812994475138 | |||
| 10010252 |
Methyl- |
150403-96-6 | >98% |
|
2008-02-12 | 15.730469613259 | methyl-l-nio-hydrochloride | NOS L-arginine NO nitric oxide nNOS eNOS iNOS inhibitor inhibits inhibition vasodilation inflammation | 15.730469613259 | |||
| 500400 |
Mouse Anti- |
- |
|
2011-10-14 | 2.047790055248 | mouse-anti-type-ii-collagen-igg-assay-kit-qualitative-bovine | EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum | 2.047790055248 | ||||
| 500420 |
Mouse Anti- |
- |
|
2011-10-17 | 2.047790055248 | mouse-anti-type-ii-collagen-igg-assay-kit-qualitative-chick | EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum | 2.047790055248 | ||||
| 500410 |
Mouse Anti- |
- |
|
2011-10-14 | 6.012430939226 | mouse-anti-type-ii-collagen-igg-assay-kit-quantitative-bovine | EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum | 6.012430939226 | ||||
| 500430 |
Mouse Anti- |
- |
|
2011-10-17 | 2.047790055248 | mouse-anti-type-ii-collagen-igg-assay-kit-quantitative-chick | EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum | 2.047790055248 | ||||
| 500470 |
Mouse Anti- |
- |
|
2011-10-17 | 2.047790055248 | mouse-anti-type-ii-collagen-igg-assay-kit-quantitative-mouse | EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum | 2.047790055248 | ||||
| 10004910 | Mouse Macrophage Microsomal Immunoblot Control | - | 2004-11-09 | 31.015125844076 | mouse-macrophage-microsomal-immunoblot-control | Mouse macrophage microsomes protein | western blots blotting microsomes immunoblots immunoblotting positive controls COX-2 COX2 PGHS-2 PGHS2 cyclooxygenases prostaglandins synthases cultures SDS-PAGE | 31.015125844076 | ||||
| 13746 | MyD88 Polyclonal Antibody | - |
|
2010-02-05 | 29.845635359116 | myd88-polyclonal-antibody | proteins antibodies western blots blotting immunoblotting WB interleukin-1 interleukins 1 IL-1 ILs signaling N-terminal NF-κB NFκB NF κB death domain signalling | 29.845635359116 | ||||
| 10006438 | Myeloperoxidase Chlorination Assay Kit | - |
|
2009-04-14 | 121.104516574585 | myeloperoxidase-chlorination-assay-kit | MPO Chlorination Assay Kit | heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes APF 2-[6-(4-aminophenoxy)-3-oxo3H-xanthen-9-yl]-benzoic acid hypochlorite -OCl | 121.104516574585 | |||
| 700170 | Myeloperoxidase Inhibitor Screening Assay Kit | - |
|
2009-04-14 | 99.838640883977 | myeloperoxidase-inhibitor-screening-assay-kit | MPO Inhibitor Screening Assay Kit | heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]-benzoic acid APF -OCl assays | 99.838640883977 | |||
| 700160 | Myeloperoxidase Peroxidation Assay Kit | - |
|
2009-04-14 | 110.108651933701 | myeloperoxidase-peroxidation-assay-kit | MPO Peroxidation Assay Kit | heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin | 110.108651933701 | |||
| 10007704 |
N- |
183718-75-4 | >98% |
|
✓ | 2007-02-02 | 9.847955801105 | n-3-hydroxyphenyl-arachidonoyl-amide | 3-HPAA | neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA cannabinoids cbs synthetic | 9.847955801105 | |
| 10008284 |
N- |
849067-18-1 | ≥98% |
|
✓ | 2006-05-10 | 15.836408839779 | n-acetyl-2-carboxy-benzenesulfonamide | analogs aspirin inhibits inhibitors inhibition cyclooxygenaes COX-1 COX-2 COX1 COX2 | 15.836408839779 | ||
| 11189 |
N- |
- | ≥95% by HPLC | 2012-02-02 | 32.668493069690 | n-acetyl-pro-gly-pro-peptide | N-acetyl-PGP | chemokines receptors ligands COPD cystic fibrosis neutrophils infiltration PMN chemoattractants CXC ECM PGP metabolites BAL bronchoalveolar inflammation inflammatory diseases | 32.668493069690 | |||
| 579040 | Nampt/Visfatin (mouse/rat) EIA Kit | - |
|
2011-08-08 | 24.981108782625 | nampt-visfatin-mouse-rat-eia-kit | Nicotinamide Phophoribosyltransferase/Visfatin | Pre-B-Cell Colony-Enhancing Factor/Visfatin immunometric kits measures measurements EIA enzymes immunoassays nicotinamides phosphoribosyltransferases coenzymes salvage pathways adenine dinucleoties NAD+ cellular metabolisms pre-B-cell cells colony enhancing factors PBEF visceral fats plasmas obesity insulin receptors proteins intracellular extracellular mesangial kidneys glucose uptake diabetic nephropathy exercise skeletal muscles NAD+-dependant sirtuin-dependant circadian oscillations cancers apoptosis serums body mass index mass inflammation livers cirrhosis beta .beta. β leukocytes tissues mouse | 24.981108782625 | |||
| 16841 |
NBD- |
- | ≥96% |
|
2009-08-04 | 75.104069981583 | nbd-fty720-phenoxy-hydrochloride | sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 fluorescent fluorescence FTY720-phosphates sphingosines immunosuppression immune modulators transporters cPLA2 cytosolic phospholipases A2 phosphorylation | 75.104069981583 | |||
| 13570 |
N- |
186545-76-6 | ≥98% |
|
2010-02-11 | 34.912016574585 | n-benzylacetamidine-hydrobromide | NO nitric oxide synthases NOS iNOS inflammation immune responses eNOS inhibitors inhibits inhibition inflammatory alpha-D-N-Acetyl-Galactosaminyloligosaccharidase alpha D N Acetyl Galactosaminyloligosaccharidase alpha-D-N-Acetylgalactosaminyloligosaccharidase alpha D N Acetylgalactosaminyloligosaccharidase endo-N-Acetyl-alpha-D-Galactosamidase endo N Acetyl alpha D Galactosamidase endo-alpha-N-Acetylgalactosaminidase endo alpha N Acetylgalactosaminidase N-Acetyl-alpha-D-Galactosaminidase N Acetyl alpha D Galactosaminidase alpha-N-Acetyl-D-galactosaminidase alpha N Acetyl D galactosaminidase alpha-N-Acetylgalactosaminidase alpha N Acetylgalactosaminidase alpha-Galactosidase B alpha Galactosidase B | 34.912016574585 | |||
| 10009818 |
NF- |
- | >75% | 2007-06-20 | 24.009060773481 | nf-b-p50-human-recombinant | NF-κB1; Nuclear Factor-κB (p50) | transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b | 24.009060773481 | |||
| 13755 |
NF- |
- |
|
2010-02-05 | 12.341988950276 | nf-b-p50-monoclonal-antibody-clone-2j10d7 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors cytokines UV radiations stress injury bacterial viral cells growth differentiation proliferation apoptosis inflammation DNA AIDS cancers arthritis western blots blotting immunoblotting IHC WB immunohistochemistry | 12.341988950276 | ||||
| 13754 |
NF- |
- |
|
2010-04-27 | 11.631353591160 | nf-b-p50-polyclonal-antibody | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors DNA p65 N-terminal binding western blots blotting immunoblotting WB antibodies | 11.631353591160 | ||||
| 10010184 |
NF- |
- | Whole cell lysate | 2007-07-19 | 23.556764009471 | nf-b-p50-western-ready-control | Nuclear Factor-κB (p50); NF-κB1 | western blot WB transcription factors p50 p105 p52 p100 regulating cytokines chemokines immunoreceptors cell adhesion molecules mammals | 23.556764009471 | |||
| 13756 |
NF- |
- |
|
2010-02-11 | 20.124822415153 | nf-b-p65-monoclonal-antibody-biotin-clone-112a1021 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones | 20.124822415153 | ||||
| 13752 |
NF- |
- |
|
2010-02-11 | 20.313535911601 | nf-b-p65-monoclonal-antibody-clone-112a1021 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC | 20.313535911601 | ||||
| 13751 |
NF- |
- |
|
2010-02-11 | 20.545580110496 | nf-b-p65-nls-polyclonal-antibody | Nuclear Factor-κB (p65) Nuclear Localization Signal | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies | 20.545580110496 | |||
| 13757 |
NF- |
- |
|
2010-02-11 | 14.566101026045 | nf-b-p65-polyclonal-antibody-aa-2-17 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 | 14.566101026045 | ||||
| 13753 |
NF- |
- |
|
2010-02-11 | 19.484806629834 | nf-b-p65-polyclonal-antibody-aa-538-546 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 | 19.484806629834 | ||||
| 10006966 |
Nitrotyrosine Monoclonal Antibody - |
- | 2005-04-15 | 9.714060773480 | nitrotyrosine-monoclonal-antibody-biotinylated | antibodies western blots blotting WB antisera antiserum peroxynitrite western blots blotting nitric oxide nitration proteins NO superoxide alzheimer's diseases oxidative injury stress IHC immunohistochemistry IP immunoprecipitation EIA enzyme immunoassay species independent detection immunoblotting Enzyme-linked immunosorbent assays | 9.714060773480 | |||||
| 13390 |
N- |
131391-65-6 | >97% |
|
2008-10-15 | 85.482108655616 | n-methyl-leukotriene-c4 | N-methyl LTC4 | allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics | 85.482108655616 | ||
| 10004971 |
N,N'- |
2387-23-7 | ≥98% |
|
2010-03-17 | 22.350718232044 | n-n-dicyclohexylurea | DCU; NSC 17013 | hypertension Epoxyeicosatrienoic acids EETs soluble epoxide hydrolase sEH inhibitors inhibits inhibiting PPARα 1,3-dicyclohexylurea dicyclohexylcarbodiamide Doms-Adrian Brand of Alanine Doms Adrian Brand of Alanine Alanine Doms-Adrian Brand Alanine, L-Isomer Alanine, L Isomer L-Isomer Alanine L-Alanine L Alanine Alanine Abufène | 22.350718232044 | ||
| 10004942 | Nod2 Monoclonal Antibody (Clone 2D9) | - |
|
2004-09-08 | 8.118306931246 | nod2-monoclonal-antibody-clone-2d9 | antisera antibody antibodies nod1 apoptosis nf kb nf-kb nf-.kappa.b nf-kappab crohn's diseases inflammations inflammatory bowel nod-2 nod-1 antiserum apoptosis caspases CARDs western blots blotting WB immunohistochemical immunohistochemistry IHC nfkb immunoblotting | 8.118306931246 | ||||
| 11040 |
Nodinitib- |
799264-47-4 | ≥95% |
|
2012-01-20 | 11.548480010440 | nodinitib-1 | ML130; CID-1088438 | NOD1 NLR innate immunity NF-κB signaling inflammation MAPK inflammatory diseases inhibitors inhibition inhibits NACHT leucine proteins bacterial bacteria ligands stress kinases interferons polymorphisms genes asthma bowel multiple sclerosis MS cells CD83 CD86 HLA-DR IL-1β IL-6 TNFα | 11.548480010440 | ||
| 10005705 |
NO- |
301838-28-8 | >98% |
|
✓ | 2004-10-20 | 5.517237569061 | no-indomethacin | NCX 2121 | inhibition inhibitors NSAIDs non-steroidal anti-inflammatory drugs inhibits nitric oxides cancer chemopreventative donor gastrointestinal NOs PaCa-2 PaCa2 pancreatic analgesic | 5.517237569061 | |
| 10010411 |
NS- |
475086-01-2 | ≥98% |
|
2008-04-09 | 39.075902394106 | ns-304 | ACT-293987; Selexipag | prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs | 39.075902394106 | ||
| 11726 | Oleanolic Acid New | 508-02-1 | ≥95% |
|
2012-05-16 | 103.859163597298 | oleanolic-acid | NSC 114945; Oleanoic Acid; Caryophyllin; Gledigenin 1; Giganteumgenin C; Astrantiagenin C; Virgaureagenin B | herbals medicines inflammation cancers viruses hyperlipidemia squalene antiinflammatory anti-inflammatory anti-hyperlipidemic antihyperlipidemic hepatoprotective in vivo antiviral anti-viral anti-tumors antitumor triterpenoids Michael addition Keap1 IKK JAK1 STAT3 PTEM proteins actin cytoskeleton oleonolic acid | 103.859163597298 | ||
| 10011301 | p38 MAPK Monoclonal Antibody (Clone 9F12) | - |
|
2008-05-22 | 3.323351749539 | p38-mapk-monoclonal-antibody-clone-9f12 | p38 Mitogen-activated Protein Kinase; p38 MAPKα | serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC | 3.323351749539 | |||
| 10784 | PAD1 (human recombinant) | - | ≥95% |
|
2011-05-12 | 47.737265193370 | pad1-human-recombinant | Protein-Arginine Deiminase 1 | PAD1 PADI-1 arginine deiminase post-translational modifications citrullination skin keratinocytes calcium-dependent active | 47.737265193370 | ||
| 500930 | PAD4 Autoantibody EIA Kit | - |
|
2011-08-18 | 16.738756906077 | pad4-autoantibody-eia-kit | Protein Arginine Deiminase 4; Peptidylartginine Deaminase 4 | peptidylarginine deiminase proteins arginines deiminases 4 guanidine guanidino-modifying enzymes amidinotransferases superfamily homodimers transcriptional coregulators catalyzes residues citrulline calcium-dependent rheumatoid arthritis RA arthritogenic autoantibodies citrullinated peptides cyclics CCP anti-CCP immunoassays immunometrics assays kits measures measurement isotypes IgM IgG IgA human plasmas serums | 16.738756906077 | |||
| 10500 | PAD4 (human recombinant) | - | ≥95% |
|
2010-05-27 | 68.342983425414 | pad4-human-recombinant | Peptidylarginine Deiminase 4; Protein Arginine Deiminase 4 | guanidino modifying enzymes citrillination histones deiminase MS multiple sclerosis Alzheimer's diseases glaucoma IOP intraocular pressure cancers peptidylarginine deiminase active | 68.342983425414 | ||
| 10279 | PAF Acetylhydrolase (human recombinant) | - | ≥95% |
|
2008-06-19 | 20.216393054459 | paf-acetylhydrolase-human-recombinant | Lp-PLA2; PAF-AH; Platelet-Activating Factor Acetylhydrolase; Lipoprotein PLA2 | proteins PAFs lipids mediator inflammation PAFAH enzymes PAF AH phospholipases PLA2s inflammatory N-terminal His-tags His-tagged active | 20.216393054459 | ||
| 10010081 | PAF Acetylhydrolase (human) Western Ready Control | - |
|
2007-05-30 | 2.592640883977 | paf-acetylhydrolase-human-western-ready-control | PAF-AH; Lp-PLA2; Platelet-activating Factor Acetylhydrolase; Lipoprotein PLA2 | western blotting WB atherosclerosis factors asthma inflammation PAFs | 2.592640883977 | |||
| 360900 |
PAF C- |
- | ≥99% deuterated forms (d1-d4) |
|
16.246022099448 | paf-c-16-d4 | Platelet-activating Factor C-16-d4 | PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis | 16.246022099448 | |||
| 10010521 |
Palmitoyl thio- |
113881-60-0 | ≥98% |
|
2008-05-23 | 7.895690607734 | palmitoyl-thio-pc | thioesters PLA2s substrates sPLA2 cPLA2 sn-2 analogs absorbance micelle systems | 7.895690607734 | |||
| 70080 | Parthenolide New | 20554-84-1 | ≥98% |
|
2012-05-18 | 92.222222222222 | parthenolide | 119325-19-8 120852-67-7 344906-67-8 leishmania apoptosis cancers genes regulations inflammation NF-kB lactones plats feverfew Tanacetum parthenium T. promastigote Leishmania amazonensis L. STAT mediated anti-apoptotic transcriptions inhibits inhibiting inhibition NOD2 | 92.222222222222 | |||
| 10992 | PAX5 Polyclonal Antibody New | - |
|
2011-12-06 | 0E-12 | pax5-polyclonal-antibody | BSAP | transcription factors B cells development IL-7 phosphorylated STAT5 Western blots blotting WB IL7 IL 7 STAT-5 STAT 5 PAX-5 PAX 5 | 0E-12 | |||
| 10010907 |
PF- |
898235-65-9 | >98% |
|
2008-03-26 | 6.130267743306 | pf-622 | FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry | 6.130267743306 | |||
| 10010908 |
PF- |
959151-50-9 | >98% |
|
2008-03-25 | 11.054506215470 | pf-750 | FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry | 11.054506215470 | |||
| 13454 | PGDM New | 133161-96-3 | ≥90% (mixture) |
|
2012-02-02 | 35.393593482440 | pgdm | Prostaglandin D Metabolite | PGD-M urine PGD2 prostaglandins D2 PGs metabolites urinary side chains cyclization biomarkers endogenous allergic asthmatic sleep body temperatures (1R,2R,3S,5S)-2-[(2Z)-4-carboxy-2-buten-1-yl]-3,5-dihydroxy-γ-oxo-cyclopentanehexanoic acid | 35.393593482440 | ||
| 11344 |
PGDM- |
- | ≥99% deuterated forms (d1-d4) |
|
2012-02-02 | 35.913067166651 | pgdm-d4 | Prostaglandin D Metabolite-d4 | PGD-M deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry urine PGD2 prostaglandins D2 PGs metabolites urinary side chains cyclization biomarkers endogenous allergic asthmatic sleep body temperatures | 35.913067166651 | ||
| 500290 | Phagocytosis Assay Kit (IgG FITC) | - |
|
2009-04-09 | 143.746594904470 | phagocytosis-assay-kit-igg-fitc | kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba | 143.746594904470 | ||||
| 600540 | Phagocytosis Assay Kit (IgG PE) New | - |
|
2012-01-10 | 108.089974089607 | phagocytosis-assay-kit-igg-pe | kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba phycoerythrins probes fluorescence | 108.089974089607 | ||||
| 10009210 |
PIK- |
372196-67-3 | ≥98% |
|
2010-03-10 | 13.776209126253 | pik-75 | p110α PI3K insulin signaling signals cancers inhibitors inhibits inhibition signalling p110a phosphatidylinositol 3-kinase phosphorylation Akt activation mTORC1 PIP2 PIP3 p110β p110α p110γ p110beta p110 alpha p110.beta. p110.alpha. p110gamma p110.gamma.p110g Mixtures, Sulfonamide Sulfonamide Mixtures Sulfonamides | 13.776209126253 | |||
| 9001155 | Piperlonguminine New | 5950-12-9 | ≥98% |
|
2012-03-01 | 13.498262095450 | piperlonguminine | N-Isobutylpiperamide; NSC 125178 | piperlonguminin alkaloids antifungals anticancers antihyperlipidemic anti-inflammatory amyloid β peptides Alzhaimer’s diseases alkaloids humans neuroblastoma cells proteins | 13.498262095450 | ||
| 13368 | Piroxicam | 36322-90-4 | ≥95% |
|
2010-01-06 | 3.501417463240 | piroxicam | NSC 666076; Larapam; Feldene | inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory Piroxicam CP-16171 CP 16171 Feldene CP16171 | 3.501417463240 | ||
| 11725 | Platycodin D Exclusive New | 58479-68-8 | ≥98% |
|
✓ | 2012-05-17 | 91.111111111111 | platycodin-d | saponin herbal medicine inflammation respiratory diseases platycodon grandiflorum P. roots upper disorders platycodin-D Chinese | 91.111111111111 | ||
| 11004 |
Podoplanin Monoclonal Antibody (Clone NZ- |
- |
|
2011-08-05 | 0E-12 | podoplanin-monoclonal-antibody-clone-nz-1-2 | Aggrus; gp38; T1A | mucin glycoproteins T1A gp38 aggrus tumors cells ligands CLEC-2 metastases tissues Th17 CD4+ humans PBMC antibodies | 0E-12 | |||
| 11005 |
Podoplanin Monoclonal Antibody (Clone pmab- |
- |
|
2011-08-05 | 0E-12 | podoplanin-monoclonal-antibody-clone-pmab-1 | gp38; Aggrus; T1A | gp38 glycoproteins tissues lymphatic endothelial cells tumors lymphangiogenesis Th17 autoimmune diseases antibodies myelin antigens migration inflammation | 0E-12 | |||
| 10007685 | PPARγ Ligand Screening Assay Kit | - |
|
2009-07-16 | 45.958161727774 | ppar-ligand-screening-assay-kit | Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green | FP-based peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists | 45.958161727774 | |||
| 13327 |
PPM- |
65240-86-0 | ≥95% |
|
2010-09-15 | 9.159502762431 | ppm-18 | NSC 73233 | inhibitors inhibits inhibition NF-κB NFκB NF κB NF-kB NFkB kB iNOS inflammation sepsis inducible nitric oxides synthases inflammatory NO Naphthalenediones Naphthoquinones Naphthazarins | 9.159502762431 | ||
| 10006973 | Pravadoline | 92623-83-1 | ≥98% |
|
2011-02-08 | 49.868317154124 | pravadoline | WIN 48,098 | Anti-inflammatory analgesic COX inhibitors pain AAI NSAIDs inhibits inhibition prostaglandins PGs synthesis murine inhibited mouse cyclooxygnases opoid Indoles receptors WIN48098 WIN-48098 WIN 48098 WIN-48,8098 | 49.868317154124 | ||
| 500940 | Progranulin (human) EIA Kit | - |
|
2011-04-26 | 31.976145346366 | progranulin-human-eia-kit | PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants | 31.976145346366 | ||||
| 500950 | Progranulin (mouse) EIA Kit | - |
|
2011-04-26 | 38.552602823818 | progranulin-mouse-eia-kit | murine mice PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants | 38.552602823818 | ||||
| 11188 |
Prolyl- |
- | ≥95% by HPLC | 2012-02-02 | 32.868001841620 | prolyl-glycyl-proline-peptide | PGP | LTA4 hydrolases substrates COPD cystic fibrosis neutrophils infiltration CF MMP-8 MMP-9 CXCR1 CXCR2 chemoattractants | 32.868001841620 | |||
| 10011724 |
Propenyl- |
- | ≥90% |
|
✓ | 2008-08-19 | 8.798936464088 | propenyl-l-nio-hydrochloride | ENIPO | nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition | 8.798936464088 | |
| 11510 | Prostaglandin Bx Exclusive | 39306-29-1 | Mixture of oligomers | ✓ | 28.204401473296 | prostaglandin-bx | PGBx | PGBx free radicals antioxidants prostaglandins | 28.204401473296 | |||
| 512031 | Prostaglandin D2 EIA Kit | - |
|
2010-07-19 | 203.609714548802 | prostaglandin-d2-eia-kit | PGD2 ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | 203.609714548802 | |||
| 512041 | Prostaglandin D2 Express EIA Kit | - |
|
2010-07-19 | 105.423217169570 | prostaglandin-d2-express-eia-kit | PGD2 Express ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | 105.423217169570 | |||
| 10006593 |
Prostaglandin D Synthase (hematopoietic- |
- | ≥95% | 2005-02-16 | 27.636114180479 | prostaglandin-d-synthase-hematopoietic-type-human-recombinant | Hematopoietic-PGDS; H-PGDS; PGD Synthase (hematopoietic-type; human recombinant) | prostaglandins synthases PGDs PGD2 HPGDS H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators active | 27.636114180479 | |||
| 10009625 |
Prostaglandin D Synthase (hematopoietic- |
- | 2007-07-19 | 21.429212707182 | prostaglandin-d-synthase-hematopoietic-type-human-recombinant-western-ready-control | Hematopoietic-PGDS; H-PGDS | western blot WB PGH2 lipocalin-type hematopoietic peripheral tisses antigen-presenting cells mast megakaryocytes allergic HPGDS H-PGDS inflammatory diseases inhibits inhibitor inhibition E. coli | 21.429212707182 | ||||
| 10004347 |
Prostaglandin D Synthase (hematopoietic- |
- | ≥85% | ✓ | 2008-06-05 | 33.375506445672 | prostaglandin-d-synthase-hematopoietic-type-mouse-recombinant | H-PGDS; Hematopoietic-PGDS | PGH2 lipocalin-type .beta.-trace prostaglandins hematopoietic enzymes PGD2 proteins recombinant inflammation activity high throughput screening inhibitors inhibits inhibition assays HPGDS H-PGDS active | 33.375506445672 | ||
| 10006595 | Prostaglandin D Synthase Inhibitor Screening Assay Kit | - |
|
2005-08-31 | 33.210460405156 | prostaglandin-d-synthase-inhibitor-screening-assay-kit | PGDS Inhibitor Screening Assay Kit | prostaglandins synthases inhibitors PGDS assays hematopoietic-types lipocalin-types pro-inflammatory mediators allergic allergy allergies allergens activity inhibitors inhibition inhibits H-PGDS L-PGDS | 33.210460405156 | |||
| 10006788 |
Prostaglandin D Synthase (lipocalin- |
- | ≥95% | 2005-03-23 | 38.766714022625 | prostaglandin-d-synthase-lipocalin-type-human-recombinant | L-PGDS; Lipocalin-PGDS | prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds active | 38.766714022625 | |||
| 10009741 | Prostaglandin D Synthase (lipocalin type; human) Western Ready Control | - | 2007-04-30 | 1.697615101289 | prostaglandin-d-synthase-lipocalin-type-human-western-ready-control | L-PGDS; Lipocalin-PGDS | GST lpgds l-pgds western blot WB neurochemistry hL-PGDS hLPGDS | 1.697615101289 | ||||
| 10006787 |
Prostaglandin D Synthase (lipocalin- |
- | ≥95% | 2005-03-23 | 42.061845953851 | prostaglandin-d-synthase-lipocalin-type-mouse-recombinant | L-PGDS; Lipocalin-PGDS | prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds active | 42.061845953851 | |||
| 10010548 |
Prostaglandin D Synthase (lipocalin- |
- | ≥95% | ✓ | 2008-07-01 | 40.950246493837 | prostaglandin-d-synthase-lipocalin-type-rat-recombinant | L-PGDS; Lipocalin-PGDS | prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds active | 40.950246493837 | ||
| 14010 | Prostaglandin E2 | 363-24-6 | ≥99% |
|
254.887908687252 | prostaglandin-e2 | PGE2; Dinoprostone | PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 | 254.887908687252 | |||
| 514018 | Prostaglandin E2 Affinity Purification Kit (20 ml) | - | 255.212386740331 | prostaglandin-e2-affinity-purification-kit-20-ml | PGE2 Affinity Purification Kit | PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies | 255.212386740331 | |||||
| 500450 | Prostaglandin E2 Affinity Purification Kit (4 ml) | - | 2010-07-28 | 199.876045777427 | prostaglandin-e2-affinity-purification-kit-4-ml | PGE2 | PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies | 199.876045777427 | ||||
| 10581 |
Prostaglandin E2- |
- | ≥99% deuterated forms (d1-d9) |
|
2010-09-16 | 96.365778084715 | prostaglandin-e2-d9 | PGE2-d9; Dinoprostone-d9 | PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards | 96.365778084715 | ||
| 514010 |
Prostaglandin E2 EIA Kit - |
- |
|
1871.181459902895 | prostaglandin-e2-eia-kit-monoclonal | PGE2 EIA Kit - Monoclonal; Prostaglandin E2 ELISA Kit - Monoclonal | solid plates kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs assays PGE2 | 1871.181459902895 | ||||
| 500141 | Prostaglandin E2 Express EIA Kit | - |
|
508.996737569060 | prostaglandin-e2-express-eia-kit | PGE2 Express EIA Kit; Prostaglandin E2 Express ELISA Kit | solid plates kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs same-day assays | 508.996737569060 | ||||
| 500501 |
Prostaglandin E2 FPIA Kit - |
- |
|
153.291009821976 | prostaglandin-e2-fpia-kit-green | PGE2 Fluorescence Polarization Immunoassay - Green | kitrecommendation:pge2 metabolites EP1 EP2 EP3 EP4 prostaglandins immunoassays HTS fluorescent high-throughput kits screenings fluorescence fluorometric assays | 153.291009821976 | ||||
| 10384 | Prostaglandin E2 isopropyl ester Exclusive | 71845-66-4 | ≥98% |
|
✓ | 2010-06-07 | 344.740252565114 | prostaglandin-e2-isopropyl-ester | PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic | 344.740252565114 | ||
| 10007211 | Prostaglandin E2 Lipid Maps MS Standard | 363-24-6 | >99% |
|
2008-11-05 | 17.902946593001 | prostaglandin-e2-lipid-maps-ms-standard | Dinoprostone; PGE2 | PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS | 17.902946593001 | ||
| 10007939 |
Prostaglandin E Synthase- |
- | 16,000 x g supernatant | 2009-03-15 | 26.335432780847 | prostaglandin-e-synthase-1-microsomal-human-recombinant | Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 | enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 active PTGES | 26.335432780847 | |||
| 10009734 |
Prostaglandin E Synthase- |
- | 2007-05-01 | 10.028004143646 | prostaglandin-e-synthase-1-microsomal-western-ready-control | mPGE Synthase-1; PIG12; Memebrane-Associated PGES-1; Prostaglandin H/E Isomerase; MGST-L1 | western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 PTGES | 10.028004143646 | ||||
| 10010498 | Prostaglandin E Synthase (cytosolic) (human recombinant, inactive protein) | - | 22.3 kDa (His-tagged); 18 kDa (native) | 2008-01-22 | 6.213270718232 | prostaglandin-e-synthase-cytosolic-human-recombinant-inactive-protein | Hsp90 Co-chaperone; p23; Telomerase-binding protein p23; cPGE Synthanse; cPGES | cPGES cPGE synthases telomerase-binding proteins p23 Hsp90 cochaperone PGES cytosolic enzymes PTGES | 6.213270718232 | |||
| 10009735 | Prostaglandin E Synthase (cytosolic) Western Ready Control | - |
|
2007-04-02 | 11.586441988950 | prostaglandin-e-synthase-cytosolic-western-ready-control | Hsp 90 Co-chaperone; p23; cPGE Synthase; cPGES; Telomerase-binding protein p23 | telomerase-binding protein p23 blotting blots western WB glutathione dependent enzymes pges PTGES | 11.586441988950 | |||
| 10009746 | PTEN (human recombinant) | - | ≥95% | 2008-09-04 | 2.475679558010 | pten-human-recombinant | TEP1; Phosphatidylinositol 3-phosphatase; MMAC1; Phosphatase and Tensin Homology on Chromosome 10 | proteins PTENs phosphatase homology tensin chromosomes enzymes lipids Sf21 cells recombinant N-terminal tumor suppressor cancers phosphoinositide hexahistidine His-tag His-tagged active | 2.475679558010 | |||
| 10009747 | PTEN Western Ready Control | - | 2007-05-30 | 0.421731123388 | pten-western-ready-control | TEP1; MMAC1; Phosphatidylinositol 3-phosphatase; Phosphatase and Tensin Homology on Chromosome 10 | western blot WB AKT phosphatidylinositol 3,4,5-triphosphate PIP3 enzyme transduction pathway endocrinology | 0.421731123388 | ||||
| 13000 | Pterostilbene | 537-42-8 | ≥98% |
|
2009-09-09 | 26.284175217048 | pterostilbene | 3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene | resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory | 26.284175217048 | ||
| 10009594 | Pyocyanin | 85-66-5 | ≥98% |
|
2007-07-12 | 33.609116022099 | pyocyanin | Pyocyanine; Sanazin; Sanasin | Pseudonomas aeruginosa phenazine metabolite neutrophil apoptosis Cystic fibrosis | 33.609116022099 | ||
| 13294 | Pyrrophenone | 341973-06-6 | ≥90% |
|
2010-04-07 | 48.304680347276 | pyrrophenone | phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory Pyrrolidines | 48.304680347276 | |||
| 10006734 | QNZ | 545380-34-5 | >98% |
|
2005-12-16 | 24.020738950276 | qnz | CAY10470 | inhibits inhibitor inhibition NF kB NF-kB NF-.kappa.B nuclear factors transcription proinflammatory cytokines TNFa TNF.alpha. interleukins IL-1b IL-1.beta. IL-6 IL-8 activation Jurkat cells LPS lipopolysaccharides murine splenocytes in vivo edema carrageenin rat hind paw NF-kappaB nfkb nf-kb NF-.kappa.B | 24.020738950276 | ||
| 10006045 |
(R)- |
- | >98% |
|
2004-11-09 | 37.513867403315 | -r-butaprost-free-acid | 15-deoxy-16R-hydroxy-17-cyclobutyl PGE1; (±)-15-deoxy-16R-hydroxy-17-cyclobutyl PGE1 | PGE2 prostaglandins 5,6-dehydro-butaprost free acids EP2 receptors binding selectivity carboxylic acid selective analogs C-16 (R)-epimers | 37.513867403315 | ||
| 10012554 | Resolvin D1 Exclusive | 872993-05-0 | ≥95% |
|
✓ | 2008-06-06 | 256.332392917195 | resolvin-d1 | RvD1; 17(S)-Resolvin D1 | EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 10007848 | 256.332392917195 | |
| 500380 | Resolvin D1 EIA Kit New | - |
|
2012-01-13 | 132.393375975472 | resolvin-d1-eia-kit | 17(S)-Resolvin D1; RvD1 | pain ELISAs enzymes immunoassays kits measures measurements resolvins lipids mediators eicosapentaenoic acids EPAs docosahexaenoic DHA inflammation non-inflamed state oxygenation oxygenated 15-lipoxygenase 5 lipoxygenase 15-LO 5-LO 17(R)-RvD1 17(R) epimers aspirin-treatments configurations humans polymorphonuclear leukocytes PMNL transendothelial migrations acute aspirin-triggered murine mouse mice rat model peritonitis inhibition inhibits inhibitors adjuvant-induced arthritis antihyperalgesic effects prevents attenuates post-operative pains transient receptors potentials TRP channels TRPA1 TRPV3 TRP4 anti-nociceptives phagocytes ALX GPR32 insulin sensitivity leptins (db/db) pro-inflammatory macrophages adipose tissues 10007848 17(S)-RvD1 | 132.393375975472 | |||
| 10007279 | Resolvin D2 Exclusive | 810668-37-2 | ≥95% |
|
✓ | 2010-06-25 | 140.031152498541 | resolvin-d2 | 7(S),16(R),17(S)-Resolvin D2 | EPA DHA inflammation anti-inflammatory antiinflammatory immune responses sepsis Docosahexaenoic Acid 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer) Docosahexaenoic Acid 4,7,10,13,16,19-(All-Z-Isomer) Docosahexaenoic Acid 4,7,10,13,16,19-Isomer Docosahexaenoic Acid 3,6,9,12,15,18-Isomer Docosahexaenoic Acid Dimer (All-Z Isomer) Docosahexaenoic Acid (All-Z Isomer) Acids Docosahexaenoic Docosahexaenoic Acids Acids Docosahexenoic Docosahexenoic Acids Docosahexaenoic Acid Docosahexaenoate 10007848 | 140.031152498541 | |
| 13832 |
Resveratrol 3- |
387372-17-0 | ≥95% |
|
2010-04-02 | 3.209944751381 | resveratrol-3-o-d-glucuronide | 1028964-58-0 3,5,4’-Trihydroxy-trans-Stilbene selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors | 3.209944751381 | |||
| 13900 |
Resveratrol- |
553662-69-4 | ≥98% |
|
2011-06-01 | 14.665722178374 | resveratrol-3-o-sulfate | polyphenol phytoalexin biochemicals physiological actions estrogenic antiplatelet anti-inflammatory piceid polydatin grape juices glucuronidated metabolites humans | 14.665722178374 | |||
| 13833 |
Resveratrol 4'- |
387372-20-5 | ≥95% |
|
2010-04-02 | 2.292817679558 | resveratrol-4-o-d-glucuronide | 3,5,4’-Trihydroxy-trans-Stilbene selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors | 2.292817679558 | |||
| 13616 |
(R)- |
100324-81-0 | ≥98% |
|
2010-05-27 | 1.331906077348 | -r-lisofylline | (R)-LSF; (-)-Lisofylline | pentoxifylline phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes interleukins 12 IL IFN-gamma | 1.331906077348 | ||
| 13697 |
(R)- |
1211877-36-9 | ≥98% |
|
✓ | 2010-06-22 | 102.382928176796 | -r-mg132 | ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited | 102.382928176796 | ||
| 10011132 | Rolipram | 61413-54-5 | ≥98% |
|
2008-12-16 | 11.059300184162 | rolipram | ZK 62711; SB 95952 | inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss | 11.059300184162 | ||
| 13343 |
RSC- |
337307-06-9 | ≥95% |
|
2010-02-15 | 10.927624309392 | rsc-3388 | cytosolic phospholipases A2 cPLA2 cPLA2α arachidonic acids eicosanoids platelet-activating factors PAF inhibitors inhibits inhibition inflammation dermatitis acrylamides | 10.927624309392 | |||
| 10009227 |
(R)- |
656827-86-0 | ≥98% |
|
2007-09-05 | 0.254419889503 | -r-slv-319 | CB1 CB2 receptors cannabinoids antagonists inflammation | 0.254419889503 | |||
| 13628 | Salidroside | 10338-51-9 | ≥97% |
|
2010-05-28 | 17.793057090239 | salidroside | Rhodioloside | glycosides plants Rhodiola Chinese medicine memory infections inflammation cancers diabetes fatigue apoptosis Glucosides | 17.793057090239 | ||
| 10951 | Sampling Tubes with Indomethacin | - | 2011-06-01 | 0E-12 | sampling-tubes-with-indomethacin | spi-bio spibio COX inhibitors ex-vivo thromboxane B2 TXB2 PGs prostagandins cyclooxygenase anticoagulant sampling tubes blood metabolites | 0E-12 | |||||
| 13336 | SB 225002 | 182498-32-4 | ≥95% |
|
2009-07-08 | 101.920939226519 | sb-225002 | CXCR2 IL-8RB IL-8 CXCL8 Gro-α CXCL1 inflammation chemokines neutrophils angiogenesis inhibitors colitis chemotaxis IL8 IL8RB Groα inhibition inhibits sb225002 | 101.920939226519 | |||
| 10010744 |
SC- |
146032-79-3 | >98% |
|
2010-03-09 | 17.113646408840 | sc-51322 | SC51322 SC 51322 prostaglandins E2 PGE2 receptors EP1 pain vasorelaxation inflammation PGs inflammatory signaling signalling antagonist Misoprostol, (11alpha,13Z)-(+-)-Isomer Misoprostol, (11beta,13E)-(+-)-Isomer Misoprostol (11alpha.13E,16S)-Isomer Misoprostol (11alpha,13E,16R)-Isomer Misoprostol, (11beta,13E,16S)-Isomer Misoprostol, (11beta,13E,16R)-Isomer Misoprostol (11alpha,13E)-Isomer Grunenthal Brand of Misoprostol Novopharm Brand of Misoprostol Misoprostol Grunenthal Brand Pfizer Brand of Misoprostol Misoprostol Novopharm Brand Apotex Brand of Misoprostol Misoprostol Pfizer Brand Misoprostol Apotex Brand Novo-Misoprostol Novo Misoprostol Apo-Misoprostol Apo Misoprostol Misoprostol SC-30249 SC-29333 SC 30249 SC 29333 SC30249 SC29333 Cytotec Glefos | 17.113646408840 | |||
| 10010267 |
SC- |
354812-17-2 | ≥98% |
|
2009-08-07 | 30.175450747877 | sc-514 | SC514 SC 514 inhibitors inhibits inhibitions IκB kinase IkB IKK2 NF-κB NFκB IL-1β IL1β genes expressions IL-6 IL6 IL-8 IL8 COX-2 COX2 iNOS LPS smooth muscles cells TLR2 TNF astrocytes | 30.175450747877 | |||
| 70655 |
SC- |
162054-19-5 | >98% |
|
19.554233425413 | sc-58125 | selective inhibitors inhibits COX-2 cox2 pghs2 pghs-2 prostaglandin synthases synthase-2 sc58125 cyclooxygenases diaryl heterocycles time-dependent | 19.554233425413 | ||||
| 10523 | Sirtinol New | 410536-97-9 | ≥98% |
|
2012-03-29 | 42.270114942529 | sirtinol | Sir Two Inhibitor Naphthol | inhibitors inhibits inhibition histones deacetylases sirtuins cancers inflammation plants biology cells NAD+ yeast Sir2p humans | 42.270114942529 | ||
| 13617 |
(S)- |
100324-80-9 | ≥98% |
|
✓ | 2010-05-27 | 1.174447513812 | -s-lisofylline | (S)-LSF; (+)-Lisofylline | pentoxifyllines phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes antiinflammatory inflammatory inflammation inflammed | 1.174447513812 | |
| 10009226 |
(±)- |
362519-49-1 | ≥98% |
|
✓ | 2007-01-16 | 25.542371440714 | -slv-319 | CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands cannabinoids cbs synthetic | 25.542371440714 | ||
| 10012628 |
(S)- |
133407-82-6 | ≥98% |
|
2009-02-18 | 179.218132596685 | -s-mg132 | Z-Leu-Leu-Leu-CHO | ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132 mg-132 2-LLL-CHO | 179.218132596685 | ||
| 13121 | Sodium Butyrate | 156-54-7 | ≥95% |
|
2009-07-31 | 57.741817065684 | sodium-butyrate | Butyric Acid (sodium salt) | fatty acids short chains inhibitors inhibits inhibition histones deacetylases HDACs epigenetics growth arrest differentiation apoptosis cancers inflammation genes expressions pro-inflammatory proinflammatory cytokines IFN-γ IL-6 IFNγ IL6 IL-1β IL1β IFNg | 57.741817065684 | ||
| 10012555 | Sodium Hydrogen Sulfide (hydrate) | 207683-19-0 | ≥65% |
|
2009-09-03 | 16.287560088776 | sodium-hydrogen-sulfide-hydrate | Sodium Hydrosulfide; NSC 158264; NaHS | hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 | 16.287560088776 | ||
| 10011669 | Soluble Epoxide Hydrolase (human recombinant) | - | ≥95% |
|
2008-07-02 | 10.534812154695 | soluble-epoxide-hydrolase-human-recombinant | CEH; Cytosolic Epoxide Hydrolase; sEH; Epoxide Hydrolase 2; EPHX2 | recombinant proteins mammalian hydrolases enzymes exogenous endogenous his-tags hexahistindes His-tagged anti-inflammatory inflammation sehs hydrolases hydrolysis active | 10.534812154695 | ||
| 10011671 | Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit | - |
|
2009-02-24 | 8.720009208103 | soluble-epoxide-hydrolase-inhibitor-screening-assay-kit | sEH Inhibitor Screening Assay Kit | epoxides hydrolases sEHs inhibits inhibition assays kits fluorescence-based catalyzes hydrolysis exogenous endogenous vicinal diols substrates EETs epoxyeicosatrienoic acids vasodilatory vasodilation anti-inflammatory molecules therapy therapeutics hypertension vascular diseases PHOME (3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-methyl ester 6-methoxy-2-naphthaldehyde excitation emission wavelengths a/b-hydrolases alpha/beta-hydrolases .alpha./.beta.-hydrolases enzymes homodimers C-terminal C-terminus animals models cyanohydrins cyanide ions | 8.720009208103 | |||
| 10011670 | Soluble Epoxide Hydrolase (mouse recombinant) Exclusive | - | ≥95% |
|
✓ | 2008-07-01 | 7.344784530387 | soluble-epoxide-hydrolase-mouse-recombinant | Cytosolic Epoxide Hydrolase; EPHX2; Epoxide Hydrolase 2; CEH; sEH | recombinant proteins mammalian hydrolases enzymes exogenous endogenous hexahistidine His-tag His-tagged N-terminal anti-inflammatory inflammation 10278 active | 7.344784530387 | |
| 10010146 | Soluble Epoxide Hydrolase Polyclonal Antibody | - |
|
2008-03-03 | 6.894585635359 | soluble-epoxide-hydrolase-polyclonal-antibody | Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH) | metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting | 6.894585635359 | |||
| 10010466 | SP 600125 | 129-56-6 | ≥98% |
|
2009-01-07 | 11.780883977900 | sp-600125 | 1PMV; Pyrazolanthrone; NSC 75890 | c-Jun cJun JNKs inhibitors inhibits inhibition reversible cell-permeable cells COX-2 COX2 MAP kinase MAPK genes expressions apoptosis autophagy differentiation IL-10 IL10 TNF-α TNFα IFN-γ IFNγ T-cells Tcells HeLa sp600125 | 11.780883977900 | ||
| 10008012 |
SPD- |
869998-49-2 | ≥98% |
|
✓ | 2006-08-07 | 25.937527624309 | spd-304 | TNF-.alpha. TNF.alpha. signal transduction inflammation small-molecule inhibitor cytokine apoptosis NF-kB AP-1 inhibitor antagonist SPD304 SPD 304 CAY10500 CAY 10500 SPD00000304 SPD 00000304 | 25.937527624309 | ||
| 700330 | Sphingomyelinase Inhibitor Screening Assay Kit | - |
|
2010-02-09 | 42.857868184608 | sphingomyelinase-inhibitor-screening-assay-kit | SMase | assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols | 42.857868184608 | |||
| 10348 | Sphingosine Kinase 1 (human recombinant) | - | ≥90% by SDS-PAGE |
|
2011-04-12 | 43.316690105475 | sphingosine-kinase-1-human-recombinant | SPHK1; SK1 | sphingosines phosphates ceramides apoptosis acids cells death kinases sphingomyelin growth calcium active | 43.316690105475 | ||
| 10012201 | Sphingosine Kinase 1 Polyclonal FITC Antibody Exclusive | - | ✓ | 2008-06-06 | 0.590607734806 | sphingosine-kinase-1-polyclonal-fitc-antibody | SPHK 1 | SPHK-1 metabolism sphingolipids phosphorylation sphingosine-1-phosphate cell proliferation death immunofluorescence IF flow cytometry FC western blots WB SPHKs blotting immunoblotting | 0.590607734806 | |||
| 10009237 | Sphingosine Kinase 2 (human recombinant) | - | >80% by SDS-PAGE | 2007-01-18 | 34.970201262825 | sphingosine-kinase-2-human-recombinant | SPHK 2; SK2 | signalling inflammatory enzymes proteins GenBank Accession No AF245447 SK2 SPK2 kinases sphingolipids SPHKs D-erythro-sphingosines phosphorylates sphingosine-1-phosphates S1Ps isoforms mammalian cells signals signaling pathways cancers inflammation proliferation apoptosis calcium homeostasis angiogenesis vascular maturation diseases active | 34.970201262825 | |||
| 10009563 | sPLA2 (human recombinant Type V) | - | ≥95% | 2007-01-16 | 26.160939226518 | spla2-human-recombinant-type-v | Secretory Phospholipase A2 (Group V); gVPLA2 | proteins binding enzymes secretory phospholipases recombinant E. coli catalyzes hydrolysis fatty acids sn-2 glycerophospholipids isoforms arachidonic mobilization macrophages mast cells golgi apparatus nuclear envelope plasma membranes murine bone marrow-derived rat mouse heart lung placenta spleen P388D1 electrophoresis coomassie staining active | 26.160939226518 | |||
| 10011382 | sPLA2 (human Type IIA) Western Ready Control Exclusive | - | ✓ | 2008-03-17 | 33.505856353591 | spla2-human-type-iia-western-ready-control | Secretory Phospholipase A2 (human Type IIA); sPLA2 (human synovial) | WB western blots blotting immunoblotting | 33.505856353591 | |||
| 10009739 | sPLA2 (human type V) Western Ready Control | - | 2007-05-25 | 13.856261510128 | spla2-human-type-v-western-ready-control | sPLA2 (group V); gVPLA2 | western blotting WB controls antibodies antisera antiserum phospholipases sPLA2s group secretory monoclonal | 13.856261510128 | ||||
| 10922 | SR 1001 | - | ≥98% |
|
2011-06-28 | 59.075591160220 | sr-1001 | inflammation autoimmune diseases RORα RORγ retinoic-acid-receptor-related orphans receptors IL-17 TH17 cells ligands mutiple sclerosis MS agonists differentiation PBMCs inhibits inhibitors inhibition splenocytes NCoR SR1001 SR-1001 | 59.075591160220 | |||
| 9000491 | SR 144528 | 192703-06-3 | ≥98% |
|
2009-08-05 | 72.405013812154 | sr-144528 | antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic | 72.405013812154 | |||
| 10009022 |
(S)- |
464213-10-3 | ≥98% |
|
✓ | 2007-08-16 | 0.254419889503 | -s-slv-319 | CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands | 0.254419889503 | ||
| 10846 | STAT1α/β Polyclonal Antibody | - |
|
2011-05-31 | 0E-12 | stat1-polyclonal-antibody | Signal Transducers and Activators of Transcriptions | transcriptions factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT1alpha/beta STAT1 alpha/beta signaling signalling STAT 1 STAT-1 STAT1a/b | 0E-12 | |||
| 10847 | STAT2 Polyclonal Antibody | - |
|
2011-05-31 | 0E-12 | stat2-polyclonal-antibody | Signal Transducers and Activators of Transcriptions | transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT-2 STAT 2 signaling signalling | 0E-12 | |||
| 10861 |
STAT3 (Phospho- |
- |
|
2011-05-31 | 0E-12 | stat3-phospho-tyr705-polyclonal-antibody | Signal Transducers and Activators of Transcriptions | transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT-3 STAT 3 signaling signalling | 0E-12 | |||
| 10856 | STAT5β Polyclonal Antibody | - |
|
2011-05-31 | 0E-12 | stat5-polyclonal-antibody | Signal Transducers and Activators of Transcriptions | transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT5beta STAT5 signaling signalling STAT 5 STAT-5 | 0E-12 | |||
| 10931 | STAT6 Polyclonal Antibody | - |
|
2011-07-13 | 0E-12 | stat6-polyclonal-antibody | IL-4 STAT; Signal Transducers and Activators of Transcription 6 | transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT-6 STAT 6 signaling signalling | 0E-12 | |||
| 11444 |
T- |
21259-20-1 | ≥98% |
|
2012-05-01 | 73.476923076922 | t-2-toxin | NSC 138780; Mycotoxin T-2; Fusariotoxin T-2; Insariotoxin | 9061-58-9 11051-21-1 22916-10-5 22916-18-3 25152-34-5 26400-47-5 27640-92-2 36653-66-4 60119-99-5 116163-69-0 145427-93-6 NSC-138780 NSC138780 T2 mycotoxin Toxin T2 trichothecene mycotoxins aleukia Toxin T2 inhibitors inhibits inhibition proteins synthesis cytotoxic macrophages inflammation immune responses immunosuppression Fusarium grains ribotoxic JNK/p38 MAPKs metabolism membranes phospholipids livers apoptosis mediators IL-1β TNFα nitric oxide TLR4 TLR2/6 agonists | 73.476923076922 | ||
| 10007207 |
tetranor- |
121842-79-3 | ≥98% |
|
2005-12-07 | 29.745690607734 | tetranor-12-s-hete | neuroscience peroxisomes metabolites arachidonic acids metabolisms 12-lipoxygenases 12-LOs platelets leukocytes smooth muscle cells tumors adhesion endothelial fibronectin subendothelial matrix b-oxidation .beta.-oxidation tissues Lewis lung carcinomas controlling inflammations inflammatory responses injured corneas Zellweger's syndromes peroxisomal abnormalities inability metabolizes symptoms diseases derivatives reasearch tools elucidations metabolic fate cancers ophthalmology | 29.745690607734 | |||
| 13369 |
tetranor- |
52510-53-9 | ≥98% |
|
✓ | 2011-12-15 | 46.209071232465 | tetranor-pgam | tetranor-Prostaglandin A Metabolite | tetranor-PGEM PGE2 urine metabolites prostaglandins E2 biomarkers inflammation diseases therapeutic metabolism biosynthesis tetranor PGAM tetranorPGAM PGA-M PGE-M t-PGAM t-prostaglandin | 46.209071232465 | |
| 12850 |
tetranor- |
- | ≥90% |
|
✓ | 2008-04-08 | 56.499211662181 | tetranor-pgdm | tetranor-PGD Metabolite | metabolites urinary PGD2 prostaglandins D2 urine PGD-M t-PGDM t-prostaglandin | 56.499211662181 | |
| 13564 |
tetranor- |
- | ≥90% |
|
✓ | 2012-01-19 | 22.260990059556 | tetranor-pgdm-lactone | tetranor-Prostaglandin D Metabolite lactone | urine PGD2 prostaglandins D2 tetranor PGDM PGs allergic allergy asthma anaphylaxis sleep body temperature inhibits inhibition inhibitor platelets aggregation vascular smooth muscles urinary metabolites humans mouse biomarkers biosynthesis lactones PGD-M t-PGDM t-prostaglandin | 22.260990059556 | |
| 11213 |
tetranor- |
- | ≥99% deuterated forms (d1-d6) |
|
✓ | 2012-04-09 | 59.184893783723 | tetranor-pgdm-lactone-d6 | tetranor-Prostaglandin D Metabolite lactone-d6 | PGE-M deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry tetranor PGDM PGs allergic allergy asthma anaphylaxis sleep body temperature inhibits inhibition inhibitors platelets aggregation vascular smooth muscles urinary metabolites humans mouse biomarkers biosynthesis lactones PGD-M t-PGDM t-prostaglandins | 59.184893783723 | |
| 10522 | Thapsigargin | 67526-95-8 | ≥97% |
|
2011-09-23 | 50.668617447869 | thapsigargin | calcium, ATPases, sarco/endoplasmic calcium ATPases SERCAs cells signaling activation histamine cancers tumorigenesis inflammation reticula sarcoplasmic endoplasmic | 50.668617447869 | |||
| 70480 | Tolfenamic Acid | 13710-19-5 | >99% |
|
10.637108655617 | tolfenamic-acid | Clotam | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits calcium influx | 10.637108655617 | |||
| 11111 |
Toll- |
- | 2011-11-18 | 0.572551481667 | toll-like-receptor-10-monoclonal-antibody-clone-3c10c5 | TLR10; CD290 | TLRs innate immune systems transmembrane proteins cells patterns recognition receptors PRRs pathogen-associated molecular PAMPs signaling TIR domains Flow cytometry FC TLR10 TLR-10 | 0.572551481667 | ||||
| 13582 |
Toll- |
- |
|
2009-10-10 | 1.500361240969 | toll-like-receptor-1-polyclonal-antibody | TLR1 | antibodies toll like TLRs receptor-1 receptors mammals transmembrane proteins leucine WB western blots blotting immunoblotting flow intracellular cells surface TLR2 lipids lipoproteins | 1.500361240969 | |||
| 700240 | Total Phosphatidic Acid Assay Kit | - |
|
2009-08-24 | 69.939443567482 | total-phosphatidic-acid-assay-kit | PA Assay Kit | assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin | 69.939443567482 | |||
| 11120 | TPPU Exclusive | 1222780-33-7 | ≥98% |
|
✓ | 2011-10-26 | 5.145469613259 | tppu | soluble epoxide hydrolase sEH inflammation hypertension cardiovascular disease neuroscience inhibitors inhibits inhibition pharmacokinetics | 5.145469613259 | ||
| 10012559 | TP Receptor (human) Polyclonal FITC Antibody | - | 2008-07-25 | 56.391240024554 | tp-receptor-human-polyclonal-fitc-antibody | TXA2 Receptor; Thromboxane A2 Receptor | antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting | 56.391240024554 | ||||
| 10855 | TRAF2 Monoclonal Antibody (Clone 33A1293) | - |
|
2011-05-06 | 0E-12 | traf2-monoclonal-antibody-clone-33a1293 | TRAF 2 TRAF-2 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting | 0E-12 | ||||
| 10872 | TRAF3 Polyclonal Antibody | - |
|
2011-05-26 | 1.407447513812 | traf3-polyclonal-antibody | TRAF 3 TRAF-3 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting | 1.407447513812 | ||||
| 10873 | TRAF5 Monoclonal Antibody (Clone 55A219) | - |
|
2011-05-26 | 1.407447513812 | traf5-monoclonal-antibody-clone-55a219 | TRAF 5 TRAF-5 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting | 1.407447513812 | ||||
| 10894 | TRAF6BP Polyclonal Antibody | - |
|
2011-05-26 | 1.407447513812 | traf6bp-polyclonal-antibody | TRAF6 Binding Protein; TAX1-binding protein; T6BP; TAX1BP1 | TRAF 6BP TRAF-6BP WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting | 1.407447513812 | |||
| 10874 | TRAF6 Polyclonal Antibody | - |
|
2011-05-26 | 1.407447513812 | traf6-polyclonal-antibody | TNF Receptor-Associated Factor 6 | TRAF 6 TRAF-6 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting | 1.407447513812 | |||
| 13044 | Tranilast | 53902-12-8 | ≥98% |
|
2008-08-29 | 71.116731123388 | tranilast | SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid | anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF | 71.116731123388 | ||
| 70675 |
trans- |
501-36-0 | >98% |
|
90.910582583043 | trans-resveratrol | (E)-Resveratrol | selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins 3,5,4'-trihydroxystilbene 3,5,4'-trihydroxy-trans-stilbene 3,5,4'-THS 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene (E)-stilbenes AHR antagonists aryl hydrocarbon receptors | 90.910582583043 | |||
| 13130 |
trans- |
- | ≥99% deuterated product |
|
2009-01-14 | 20.881717311234 | trans-resveratrol-d4 | (E)-Resveratrol-d4 | selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors | 20.881717311234 | ||
| 10188 |
trans- |
22255-22-7 | >98% |
|
2004-03-03 | 17.890565235869 | trans-trismethoxy-resveratrol | (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol | selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS Prostaglandins synthases antioxidants oxidative injury stress sirtuins 3,5,4'-trihydroxy stilbene 3,5,4'-trihydroxystilbene 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene trimethoxy AHR antagonists aryl hydrocarbon receptors | 17.890565235869 | ||
| 13129 |
trans- |
- | ≥99% deuterated product |
|
2009-02-09 | 18.326800184162 | trans-trismethoxy-resveratrol-d4 | (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4 | deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins AHR antagonists aryl hydrocarbon receptors | 18.326800184162 | ||
| 10010245 |
U- |
137018-55-4 | ≥98% |
|
2008-07-08 | 0.386740331492 | u-83836e | antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 PNU-83836E PNU83836E | 0.386740331492 | |||
| 10007457 | URB602 | 565460-15-3 | >98% |
|
2005-09-06 | 40.775469613259 | urb602 | monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry cannabinoids cbs synthetic | 40.775469613259 | |||
| 10072 | Ursolic Acid New | 77-52-1 | ≥98% |
|
2012-02-29 | 94.444444444444 | ursolic-acid | NSC 4060; Prunol; NSC 167406; Malol; Bungeolic Acid; Maerotaine | NSC-167406 NSC167406 NSC-4060 NSC4060 neoage UR ursolisome urson β-Ursolic 209545-05-1 triterpenoid antioxidative antimicrobial anti-inflammatory anticancer Na+ K+ ATPase NF-kB cells proliferation apoptosis inhibitions inhibitors inhibits inflammation cancers | 94.444444444444 | ||
| 10812 | Vaspin (human) Monoclonal Antibody (Clone VP63) | - |
|
2011-06-27 | 1.933011049723 | vaspin-human-monoclonal-antibody-clone-vp63 | OL-64; Visceral Adipose Tissue-Derived Serine Protease Inhibitor; Serpin A12 | antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay serpin adipocytokine immune response inflammation obesity insulin | 1.933011049723 | |||
| 10010519 | Vialinin A | 858134-23-3 | ≥98% |
|
2008-07-25 | 30.670589318599 | vialinin-a | Terrestrin A | .beta.-hexosaminidase b-hexosaminidase beta-hexosaminidase TNF-.alpha. TNF-a TNF-alpha IL-4 IL4 CCL2 MCP-1 MCP1 antiallergic anti-allergic anti-inflammatory antiinflammatory RBL-2H3 cells RBL2H3 mast antioxidant | 30.670589318599 | ||
| 10009023 |
(+)WIN 55212- |
131543-23-2 | ≥98% |
|
2006-10-05 | 59.227790192713 | -win-55212-2-mesylate | WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 cannabinoids cbs synthetic | 59.227790192713 | |||
| 13246 |
YM- |
223499-30-7 | ≥98% |
|
2009-11-16 | 5.369171270719 | ym-58483 | BTP 2 | calcium channels leukocytes leukotrienes eicosanoids inflammation asthma allergy IL-2 IL-4 lymphocytes eosinophils NF-AT CRACs CysLTs interleukin-4 BTP2 BTP-2 CysLT | 5.369171270719 | ||
| 13665 | YS121 Exclusive | 916482-17-2 | ≥98% |
|
✓ | 2010-04-02 | 17.990220994475 | ys121 | Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition Pyrimidines inhibits PGs YS 121 YS-121 | 17.990220994475 | ||
| 13271 |
ZLJ- |
1051931-39-5 | ≥98% |
|
✓ | 2009-06-17 | 36.043522099447 | zlj-6 | inhibitors cyclooxygenase COX-1 COX-2 5-lipoxygenase 5-LO inflammation pain ZLJ6 ZLJ 6 | 36.043522099447 | ||
| 10008652 |
(±)- |
7083-09-2 | ≥98% |
|
2006-10-18 | 6.539084451459 | -cmbhc | vitamin E tocopherals tocotrienols a-CEHC alpha-CEHC .alpha.-CEHC a-tocopherol alpha-tocopherol .alpha.-tocopherol metabolites g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienols HepG2 cells a-CMBHC alpha-CMBHC .alpha.-CMBHC a-CMHHC alpha-CMHHC .alpha.-CMHHC rac rifmpicin CYP3A cytochromes P450s w-oxidation omega-oxidation .omega.-oxidation b-oxidation beta-oxidation .beta.-oxidation | 6.539084451459 | |||
| 10008377 |
α- |
58864-81-6 | ≥98% |
|
2006-10-18 | 18.361993972877 | -tocotrienol | vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 toxicity HT4 cytosolic glutamatec-Src kinases 12-lipoxygenases 12-LOs | 18.361993972877 | |||
| 10008494 |
γ- |
14101-61-2 | ≥98% |
|
2006-10-20 | 15.493121546961 | -tocotrienol | g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans hypertensive hypertension systolic blood pressures NOS nitric oxides synthases vessels malignant sympathoadrenal +SA mouse murine rats mammary epithelial cells | 15.493121546961 | |||
| 10008513 |
δ- |
25612-59-3 | ≥98% |
|
2006-10-20 | 9.849244935542 | -tocotrienol | d-Tocotrienol delta-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neurons neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 cytotoxicity inhibits inhibitors inhibition HAECs U937 monocytic cells VCAM-1 | 9.849244935542 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search